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1.	  Laymen’s	  summary	  (max.	  500	  words)	  
	  
Diabetes	  is	  a	  metabolic	  disorder	  which	  is	  characterized	  by	  an	  increase	  in	  blood	  glucose	  
levels	  (Schweicher	  et	  al.,	  2014).	  Typically,	  people	  suffering	  from	  diabetes	  are	  unable	  to	  
produce	  sufficient	  amounts	  of	  (and/or	  respond	  to)	  the	  hormone	  insulin,	  which	  is	  one	  of	  
the	  main	   regulators	   of	   our	   blood-­‐glucose	   levels	   (Tuomi,	   2005).	   Insulin	   is	   secreted	   by	  
pancreatic	   beta	   cells,	   which	   reside	   in	   cell	   clusters,	   also	   known	   as	   pancreatic	   islets	   or	  
islets	  of	  Langerhans,	  scattered	  throughout	  the	  pancreas.	  Increased	  blood	  glucose	  levels	  
can	  have	  serious	  consequences,	  such	  as	  heart	  disease,	  loss	  of	  vision,	  kidney	  failure,	  and	  
even	   death	   (Nathan,	   1993).	   As	   reported	   by	   the	   World	   Health	   Organization,	   diabetes	  
affects	   over	  more	   than	   400	  million	   people	  worldwide	   and	   is	   expected	   to	   become	   the	  
seventh	  leading	  cause	  of	  death	  in	  2030.	  
	  
Currently,	  diabetes	  is	  managed	  by	  means	  of	  insulin	  administration.	  However,	  despite	  the	  
major	   advances	   in	   diabetes	   research,	   which	   have	   resulted	   in	   enhanced	   insulin	  
formulations	   and	   improved	   patients’	   quality	   of	   life,	   diabetes	   is	   still	   incurable.	   In	  
addition,	   it	   is	   known	   that	   patients	   suffering	   from	   long-­‐standing	   diabetes	   are	   prone	   to	  
develop	  recurrent	  hypoglycemia	  unawareness	  (Tomky,	  2005;	  Quan	  et	  al.,	  2015).	  This	  is	  
a	  condition	  in	  which	  patients	  are	  no	  longer	  able	  to	  detect	  dangerously	  low	  blood	  glucose	  
levels,	   which	   can	   result	   in	   life-­‐threatening	   situations.	   To	   address	   this,	   beta	   cell	  
replacement	   therapies	   have	   been	   proposed.	   One	   example	   is	   the	   pancreatic	   islet	  
transplantation.	  As	  the	  name	  indicates,	  this	  procedure	  encompasses	  the	  transplantation	  
of	  pancreatic	  islets	  from	  a	  donor	  into	  a	  patient.	  The	  pancreatic	  islets	  are	  harvested	  from	  
donor	   tissue,	  purified,	  processed	  and	   transplanted	   into	   the	  patient	  back	  via	   the	  portal	  
vein	  of	  the	  liver	  (McCall	  &	  Shapiro,	  2012;	  Moore	  et	  al.,	  2015).	  The	  idea	  is	  that	  these	  islets	  
will	  start	  to	  release	  insulin	  soon	  after	  transplantation	  and	  normalize	  the	  blood	  glucose	  
levels.	   Whereas	   the	   approach	   has	   shown	   to	   be	   promising,	   there	   are	   still	   various	  
limitations	  hindering	  its	  widespread	  application.	  The	  two	  main	  limitations	  are	  the	  lack	  
of	   sufficient	   vasculature	   and	   the	   immune	   reactions	   after	   transplantation	   (Ryan	   et	   al.,	  
2005;	  Vaithilingam	  &	  Tuch,	  2011;	  McCall	  &	  Shapiro,	  2012).	  	  
	  
In	  this	  work,	  we	  aim	  to	  address	  these	  issues	  by	  means	  of	  a	  biofabrication	  approach.	  The	  
idea	   is	   to	   develop	   a	   bioprinting	   platform	   which	   would	   be	   able	   to	   house	   and	   protect	  
islet(-­‐like)	  cells	  in	  a	  core-­‐shell,	  also	  known	  as	  co-­‐axial,	  configuration.	  This	  configuration	  
allows	  for	  controlled	  co-­‐deposition	  of	  (when	  desired)	  multiple	  materials	  along	  the	  same	  
axis.	   At	   this	   stage,	   the	   first	   steps	   were	   taken	   towards	   the	   development	   of	   a	   relevant	  
bioink,	  which	  would	  ideally	  be	  able	  to	  house	  islet(-­‐like)	  cells	  for	  over	  a	  period	  of	  at	  least	  
28	   days.	   Based	   on	   pilot	   experiments,	   2|7.5%	   w/v	   alginate|GelMA	   was	   selected	   as	   a	  
target	   material.	   The	   bioink	   was	   characterized	   in	   terms	   of	   rheological	   properties,	  
stability,	  porosity,	  and	  cytocompatibility.	  Whereas	   these	   initial	   results	  seem	  promising	  
in	  terms	  of	  housing	  relevant	  cell	  types,	  substantial	  work	  remains	  to	  be	  done,	  especially	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Pancreatic	   islet	   transplantation	   is	   emerging	   as	   a	   potential	   therapy	   for	   treatment	   of	  
patients	   suffering	   from	  diabetes	   type	   1.	  Whereas	   various	   studies	   have	   already	   shown	  
the	  ability	  of	   this	  experimental	  procedure	   to	  normalize	  blood	  glucose	   levels,	   there	  are	  
several	   factors	   hampering	   its	  widespread	   use	   and	   long-­‐term	   success.	   During	   the	   islet	  
transplantation	   procedure,	   islets	   are	   exposed	   to	   a	  myriad	   of	   cell	   stresses,	   resulting	   in	  
suboptimal	  clinical	  outcomes.	  Two	  main	  limitations	  are	  the	  lack	  of	  sufficient	  vasculature	  
and	   the	   immune	   reactions	   after	   transplantation.	   In	   this	   study,	   the	   focus	   is	   put	   on	   the	  
development	   of	   bioprinting	   platforms,	   which	   could	   assist	   in	   defining	   more	   optimal	  
transplantation	   sites.	   By	   co-­‐encapsulating	   relevant	   cell	   types	   in	   a	   protective	   hydrogel	  
environment,	   we	   envision	   to	   advance	   the	   current	   approach	   to	   pancreatic	   islet	  
transplantation.	  In	  this	  project,	  the	  emphasis	  was	  put	  on	  bioink	  development.	  Whereas	  
substantial	   work	   remains	   to	   be	   done,	   assessment	   of	   the	   target	   hydrogel	   blend	   (i.e.	  
2|7.5%	  w/v	  alginate|GelMA)	   in	   terms	  of	   rheological	  properties,	   stability,	  porosity,	  and	  
biocompatibility	  has	   shown	   the	  promise	  of	   this	  base-­‐material	   for	  biofabrication-­‐based	  




Diabetes	   is	  a	  metabolic	  disorder	  characterized	  by	  unstable	  glycemia.	  Broadly,	  diabetes	  
can	  be	  subdivided	  into	  two	  subtypes;	  diabetes	  type	  1	  and	  diabetes	  type	  2	  (Tuomi,	  2005).	  
Diabetes	  type	  1	  is	  an	  auto-­‐immune	  disorder	  and	  stems	  from	  the	  destruction	  of	  insulin-­‐
producing	   beta	   cells	   in	   the	   pancreas	   (Box	   1).	   In	   diabetes	   type	   2,	   the	   body	   becomes	  
insulin	  resistant	  and/or	  gradually	  loses	  the	  capacity	  to	  produce	  adequate	  insulin	  levels.	  
Long-­‐standing	   diabetes	   can	   have	   serious	   consequences,	   such	   as	   damage	   to	   and/or	  
dysfunction	   of	   the	   eyes,	   kidneys,	   nerves,	   heart,	   and	   blood	   vessels	   (Nathan,	   1993).	  
Despite	  our	  increased	  understanding	  of	  diabetes	  as	  a	  disease	  and	  the	  major	  advances	  in	  
diabetes	   care,	   attaining	  and	  maintaining	  glycemic	   control	   still	  poses	  a	   substantial	   task	  
(Aronoff	   et	   al.,	   2004).	   As	   reported	   by	   the	   World	   Health	   Organization,	   the	   global	  
prevalence	   of	   diabetes	   has	   almost	   doubled	   since	   1980	   and	   is	   expected	   to	   become	   the	  
seventh	  leading	  cause	  of	  death	  in	  2030.	  Clearly,	  there	  is	  an	  urgent	  need	  for	  alternative	  
treatments,	   which	   have	   the	   potential	   to	   progress	   current	   diabetes	   care	   and	   improve	  
patients’	  quality	  of	  life.	  	  
	  
As	   for	   any	   field	   to	   advance,	   developments	   within	   cooperative	   disciplines	   and	  
technologies	  play	  an	  essential	  role	  (Carter	  et	  al.,	  2016).	  In	  terms	  of	  advancing	  diabetes	  
care,	   one	   highly	   relevant	   discipline	   is	   tissue	   engineering	   and	   regenerative	   medicine	  
(TERM).	  This	  multidisciplinary	  field	  aims	  at	  tissue	  regeneration	  by	  combining	  cells	  and	  
bioactive	  factors	  with	  porous	  scaffold	  biomaterials,	  the	  latter	  guiding	  the	  growth	  of	  new	  
tissues	  (O’brien,	  2011).	  Over	  the	  years,	  TERM	  approaches	  have	  shown	  to	  be	  valuable	  for	  
a	  wide	  variety	  of	  applications,	  notable	  examples	  being	   in	   the	  area	  of	  skin	  replacement	  
and	  cartilage	  repair	  (Berthiaume	  et	  al.,	  2011;	  Shafiee	  &	  Atala,	  2016).	  Also	  regarding	  the	  
pancreas,	   these	   approaches	   have	   attracted	   much	   attention	   (Daoud	   et	   al.,	   2011).	  
Although	  shown	  to	  be	  promising,	  TERM	  strategies	  still	   face	  multiple	  challenges.	  These	  
include	   the	   identification,	   isolation,	   and	   expansion	   of	   relevant	   cell	   types,	   but	   also	   the	  
selection	   of	   appropriate	   biomaterials	   (Borg	   &	   Bonifacio,	   2011).	   Intuitively,	   these	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target	   tissue	  as	   closely	  as	  possible,	  which	  can	  be	  extremely	  challenging.	   In	  addition,	   it	  
requires	   the	   biological	   and	   functional	   integration	   of	   the	   cells	   with	   the	   surrounding	  
biomaterial(s)	  and	  integration	  of	  the	  completed	  constructs	  within	  the	  host	  environment.	  
Moreover,	  successful	  application	  of	  these	  approaches	  into	  the	  clinical	  routine	  poses	   its	  
own	  obstacles	  and	  remains	  a	  work	  in	  progress.	  	  
	  
In	  this	  respect,	  the	  converging	  field	  of	  biofabrication	  has	  several	  advantages.	  As	  recently	  
described	   by	   Groll	   et	   al.	   (2016),	   the	   term	   biofabrication	   refers	   to	   the	   automated	  
generation	  of	  products	  with	  biological	  function	  by	  means	  of	  bioprinting	  or	  bioassembly	  
and	   subsequent	   maturation	   processes.	   More	   specifically,	   biofabrication	   encompasses	  
living	   cells,	   cell	   aggregates,	   bioactive	   molecules,	   and	   biomaterials	   to	   generate	  
biologically	   functional	   products	   in	   an	   automated	   and	   highly	   organized	   manner.	  
Exploiting	  automated	  processes	  such	  as	  additive	  manufacturing	  within	  the	  field	  of	  TERM	  
has	   facilitated	   the	   development	   of	   three-­‐dimensional	   (3D)	   (composite)	   constructs,	  
mimicking	  the	  mechanical	  and	  biological	  properties	  and	  architectural	  configurations	  of	  
native	  tissue.	  	  
	  
In	   this	   work,	   initial	   steps	   are	   taken	   towards	   bioprinting	   platforms	   for	   vascularized	  
bioartificial	  pancreas	  constructs.	  Herein,	  we	  describe	  relevant	  developments	  in	  diabetes	  
care,	   with	   special	   emphasis	   on	   biofabrication-­‐based	   TERM	   approaches.	   After	   a	   brief	  
description	  of	  our	  concept,	  a	  co-­‐axial	  printing	  approach	  to	  address	  current	  limitations	  in	  
diabetes	   care,	   we	   proceed	   towards	   a	   detailed	   description	   of	   the	   used	   methods	   and	  
obtained	  results,	  which	  are	  discussed	  in	  light	  of	  the	  final	  application,	  namely,	  in	  human	  
transplantation.	  To	   conclude,	   relevant	   translational	  bottlenecks,	  which	  will	  need	   to	  be	  
considered	   as	   the	   field	   evolves,	   are	   highlighted.	   Key	   aspects	   include	   the	   necessary	  
advances	  in	  converging	  disciplines,	  ethical	  regulations,	  and	  the	  need	  for	  standardization	  
in	  the	  field.	  
	  
	  
4.	  Diabetes	  care	  
	  
4.1.	  Exogenous	  insulin	  replacement	  
Before	  the	  discovery	  of	  insulin	  in	  1921,	  diabetes	  was	  considered	  a	  terminal	  disease,	  the	  
only	   intervention	   being	   a	   strict	   diet	   (Shah	   et	   al.,	   2013;	   Shah	   et	   al.,	   2016).	   Since	   its	  
inception,	  marked	   progressions	   have	   been	  made	   in	   the	   development	   of	   insulin.	   Early	  
insulins	  were	  derived	  from	  animal	  pancreata	  (i.e.	  bovine,	  porcine)	  and	  were	  associated	  
with	   several	   drawbacks	   (i.e.	   immunologic	   reactions,	   lipodystrophy,	   and	   unpredictable	  
absorption	   rates),	  which	   hindered	   their	  widespread	   use.	  Not	   surprisingly,	   subsequent	  
research	  was	  centred	  on	  the	  purification	  of	  insulin.	  Both	  the	  discovery	  of	  the	  amino	  acid	  
sequence	   of	   insulin	   and	   the	   use	   of	   recombinant	   technology	   in	   1950	   and	   1970	  
respectively	   paved	   the	  way	   for	   the	  manufacturing	   of	   insulin	   as	   known	   today,	   namely	  
recombinant	   DNA-­‐derived	   human	   insulins.	   Nowadays,	   a	   wide	   variety	   of	   insulins	   is	  
available,	   tailored	   to	   meet	   patients’	   individual	   needs	   and	   lifestyles.	   Examples	   are	  
insulins	  with	  different	  peak	  action	   times	  and	  duration,	   to	  a	   range	  of	  delivery	   systems,	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Currently,	  the	  primary	  treatment	  for	  diabetes	  involves	  subcutaneous	  insulin	  therapy,	  it	  
being	  administered	  via	  daily	  subcutaneous	   injections	  (Bottino	  &	  Trucco,	  2015;	  Shah	  et	  
al.,	   2016).	  Although	   this	   approach	   is	   encouraging	   in	   terms	  of	  managing	  blood	   glucose	  
levels,	   pharmacologic	   insulin	   replacement	  does	  not	   completely	  match	   the	  precision	  of	  
endogenous	   beta	   cell	   insulin	   secretion	   (Home,	   2015).	   In	   addition,	   patients	  with	   long-­‐
standing	  diabetes	  are	  prone	  to	  develop	  recurrent	  hypoglycemia	  unawareness,	  a	  serious	  
condition	  in	  which	  patients	  fail	  to	  detect	  dangerously	  low	  blood	  glucose	  levels	  (Tomky,	  
2005;	  Quan	  et	  al.,	  2015).	  To	  address	  these	  clinical	  shortcomings,	  beta	  cell	  replacement	  
therapies	  such	  as	  whole	  pancreas	  transplantations	  have	  been	  proposed.	  Despite	  the	  high	  
clinical	   success	   rates,	  whole	  pancreas	   transplantation	   remains	   a	  major	   surgery	  with	   a	  
substantial	   risk	   of	   complications	   (Vaithilingam	   &	   Tuch,	   2011).	   A	   minimally	   invasive	  
alternative	  to	  this	  approach,	  avoiding	  the	  need	  for	  major	   laparotomy,	   is	  the	  pancreatic	  
islet	  transplantation.	  	  
	  
	  
4.2.	  Pancreatic	  islet	  transplantation	  
Typically,	   the	   islet	   transplantation	   procedure	   involves	   purification	   and	   processing	   of	  
pancreatic	   islets	   from	   an	   organ	   donor	   (allo-­‐transplantation)	   and	   subsequent	   infusion	  
into	  the	  patient	  via	  the	  portal	  vein	  of	  the	  liver	  (figure	  1)	  (McCall	  &	  Shapiro,	  2012;	  Moore	  
et	  al.,	  2015).	  The	  rationale	  behind	  this	  approach	  is	  that	  the	  pancreatic	  islets	  will	  start	  to	  
release	   insulin	   soon	   after	   transplantation,	   resulting	   in	   reduced	   glycemic	   lability.	   Even	  
though	  the	  concept	  of	  pancreatic	  islet	  transplantation	  dates	  back	  to	  the	  late	  19th	  century,	  
it	  was	  not	  until	  the	  Edmonton	  protocol	  in	  the	  late	  1990s	  that	  a	  significant	  improvement	  
in	   insulin	   independence	   was	   achieved	   (Shapiro	   et	   al.,	   2000;	   Robertson,	   2015).	   This	  
approach,	  which	  involved	  infusion	  of	  islets	  from	  at	  least	  two	  donors	  and	  introduction	  of	  
a	  corticoid-­‐free	  immunosuppressive	  regimen,	  resulted	  in	  1-­‐year	  insulin	  independence	  in	  
seven	   type	   1	   diabetes	   patients	   (Shapiro	   et	   al.,	   2000).	   Over	   the	   years,	   islet	   transplant	  
programs	  all	  over	  the	  world	  have	  been	  working	  on	  refinement	  of	  the	  protocols,	  in	  search	  
for	   improved	   islet	   manufacturing	   and	   clinical	   outcomes.	   To	   date,	   various	   research	  
efforts	   have	   demonstrated	   the	   potential	   of	   islet	   transplantation	   to	   tackle	   glycemic	  
Box	  1.	  Basics	  of	  glucose	  homeostasis	  
The	  pancreas	  is	  a	  unique	  abdominal	  organ,	  orchestrating	  both	  exocrine	  and	  endocrine	  
functions	   (Pepper	   et	  al.,	   2013).	   The	   bulk	   of	   the	   human	   pancreas	   consists	   of	   exocrine	  
cells,	  which	  produce	   enzymes	   important	   in	   the	   food	  digestion	  process.	   The	   endocrine	  
component	  makes	   up	   only	   1-­‐2%	   of	   the	   entire	   organ	   and	   encompasses	   the	   pancreatic	  
islets,	   also	   referred	   to	   as	   the	   islets	   of	   Langerhans	   (Stendahl	   et	   al.,	   2009).	   	   These	  
pancreatic	  islets	  contain	  a	  variety	  of	  cells,	  including	  the	  alfa	  and	  beta	  cells,	  which	  secrete	  
the	   hormones	  glucagon	   and	   insulin	   into	   the	   bloodstream	  respectively.	   Together	   these	  
hormones	  regulate	  and	  maintain	   the	  blood	  glucose	  levels	  within	  the	  narrow	  range	  the	  
body	   requires	   (i.e.	  ~4.0–7.8	   mmol/L).	  When	   the	   blood	   glucose	   level	   rises,	   pancreatic	  
beta	   cells	   secrete	   the	   hormone	   insulin.	   Insulin	   facilitates	   the	  uptake	  of	   glucose	   by	   the	  
energy-­‐storing	  organs	  (e.g.	  muscle,	   liver,	  adipose	  tissue),	   thereby	  decreasing	  the	  blood	  
glucose	  levels.	   In	  response	  to	   low	  blood	  glucose	  levels,	  pancreatic	  alfa	  cells	  secrete	  the	  
hormone	  glucagon,	  which	  opposes	  the	  actions	  of	  insulin	  (Aronoff	  et	  al.,	  2004).	  Glucagon	  
promotes	  the	   increase	   in	  glucose	   levels	  via	  glycogenolysis,	   the	  breakdown	  of	  glycogen	  
(i.e.	  principal	   storage	  form	  of	  glucose)	   into	  glucose,	  and	  gluconeogenesis,	  which	  refers	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lability,	  demonstrating	  5	  year	  insulin	  independence	  after	  treatment	  (Bellin	  et	  al.,	  2012;	  
Shapiro	  et	  al.,	  2016;	  Jin	  &	  Kim,	  2017).	  
	  
Even	   though	   the	  clinical	  outcomes	  have	   improved	  markedly,	   there	  are	  still	   substantial	  
drawbacks	   associated	   with	   pancreatic	   islet	   transplantations.	   Firstly,	   there	   are	   the	  
general	   risks	   associated	  with	   any	   surgical	   procedure	   and,	   as	   goes	   for	  whole	   pancreas	  
transplantations,	  side	  effects	  from	  the	  chronic	  immunosuppressive	  medication.	  Besides,	  
limited	   available	   donor	   tissue	   strongly	   hampers	   widespread	   application;	   typically,	  
recipients	   will	   need	   two	   transplants	   of	   ~5000	   islet	   equivalents	   per	   kilogram	   of	  
bodyweight	   (McCall	   &	   Shapiro,	   2012).	   In	   addition,	   maintaining	   islet	   function	   post-­‐
transplantation	   represents	   a	  major	   challenge	   (Ryan	   et	  al.,	   2005;	   Vaithilingam	  &	  Tuch,	  
2011;	  McCall	  &	  Shapiro,	  2012).	  Native	  islets	  in	  the	  pancreas	  are	  highly	  vascularized	  and	  
receive,	  although	  only	  comprising	  ~1%	  of	  the	  mass	  of	  the	  tissue,	  ~15%	  of	  the	  pancreatic	  
blood	  supply,	  something	  that	   is	  not	  yet	  achieved	  in	  the	  transplanted	  islets	  (Brissova	  &	  
Powers,	  2008).	  This	  high	  degree	  of	  vascularization	  is	  important	  for	  appropriate	  glucose	  
sensing	  and	  effective	   insulin	  secretion.	   In	  contrast	   to	  most	  solid	  organ	  grafts,	   in	  which	  
the	   revascularization	   process	   is	   relatively	   quickly	   re-­‐established	   by	   vascular	  
anastomoses,	  restoring	  adequate	  microcirculation	  in	  pancreatic	  islets	  grafts	  needs	  time.	  
It	  requires	  a	  process	  of	  angiogenesis	  and	  revascularization,	  which	  could	  take	  up	  to	  two	  
weeks	  (Menger	  et	  al.,	  2001;	  Morini	  et	  al.,	  2007;	  Brissova	  &	  Powers,	  2008).	  During	  this	  
period	  the	  isolated	  islets	  are	  exposed	  to	  a	  hostile,	   ischemic	  environment,	  which	  causes	  
significant	  functional	  impairment,	  compromises	  cell	  viability,	  and	  thereby	  the	  success	  of	  
islet	  transplantations.	  	  
	  
Although	   the	   liver	   has	   been	   the	   traditional	   site	   to	   infuse	   the	   donor	   islets,	   this	  
transplantation	   site	   seems	   to	   play	   a	   substantial	   role	   in	   the	   poor	   success	   rates	   post-­‐
transplantation	  (Robertson,	  2002).	  Islets	  lodged	  in	  the	  hepatic	  portal	  vein	  are	  not	  only	  
exposed	   to	   a	   lower	   oxygen	   tension,	   but	   also	   provocate	   an	   instant	   blood-­‐mediated	  
inflammatory	  reaction	  when	  in	  contact	  with	  blood	  in	  the	  portal	  vein	  (Bennet	  et	  al.,	  2000;	  
Carlsson	  et	  al.,	  2001).	  Additional	  limiting	  factors	  include	  the	  difference	  in	  glucose	  levels	  
compared	   to	   systemic	   levels	   and	   presence	   of	   metabolites	   and	   pharmaceuticals	   with	  
potential	   toxic	  effects,	  which	   together	   illustrate	   the	  necessity	  of	  extra-­‐hepatic	   sites	   for	  




Figure	   1.	   Schematic	   of	   the	   islet	   transplantation	   procedure.	   Islet	   are	   harvested	   from	   donor	   pancreata,	  
purified,	  and	  subsequently	  transplanted	  into	  the	  patients	  via	  the	  portal	  vein	  of	  the	  liver.	  Figure	  obtained	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5.	  A	  glance	  at	  pancreatic	  tissue	  engineering	  
	  
Recognition	   of	   the	   importance	   of	   a	   suitable	   microenvironment	   to	   house	   insulin-­‐
producing	  (beta)	  cells	  has	  prompted	  many	  tissue	  engineering	  approaches	  (Cantarelli	  et	  
al.,	   2017).	   The	   field	   of	   tissue	   engineering	   is	   rapidly	   expanding	   and	   involves	   the	  
constructive	   collaboration	   between	   a	   variety	   of	   research	   disciplines,	   ranging	   from	  
fundamental	  cell-­‐biology,	  to	  materials	  science,	  and	  engineering	  (figure	  2)	  (El-­‐Sherbiny	  &	  
Yacoub,	   2013).	   Regardless	   of	   the	   final	   application,	   appropriate	   selection	   of	   the	   cells,	  
biomaterials,	   and	   bioactive	   factors	   is	   essential	   to	   achieve	   long-­‐term	   satisfying	   results.	  
Careful	  selection	  of	  the	  cell	  source	  could	  improve	  the	  functionality	  of	  the	  constructs	  and	  
address	   the	   limitations	   related	   to	   current	   donor	   shortage.	  When	   it	   comes	   to	   the	   islet	  
transplantation	   procedure,	   appropriate	   biomaterials	   should	   not	   only	   provide	   support,	  
but	  also	  serve	  as	  a	  selective	  shield,	  addressing	  graft	  rejection.	  Ideally,	  this	  environment	  
would	   provide	   immuno-­‐isolation	   while	   still	   allowing	   the	   diffusion	   of	   molecules	   (e.g.	  
nutrients,	  waste	  products	  and	  hormones)	  towards	  and	  from	  the	  embedded	  cells.	  Lastly,	  
incorporation	   of	   bioactive	   factors	   (e.g.	   growth	   factors)	   could	   complement	   the	   above-­‐
mentioned	  and	  thereby	  advance	  the	  islet	  transplantation	  approach	  as	  a	  whole.	  	  
	  
5.1.	  Cells	  
Central	   to	   TERM	   and	   biofabrication	   strategies	   is	   the	   choice	   of	   the	   cells.	   Inclusion	   of	  
relevant	  cell	  types	  is	  imperative	  for	  reliable	  research,	  data	  interpretation,	  translation	  to	  
the	   human	   situation,	   and	   success	   of	   the	   therapy.	   Given	   that	   the	   current	   supply	   of	  
available	  donor	  tissue	  cannot	  equal	  the	  demand,	  new	  research	  areas	  have	  opened	  up	  in	  
search	   for	   (establishing)	  alternative	   insulin-­‐producing	  cell	   sources	   (Bruns	  et	  al.,	   2013;	  
Moore	  et	  al.	  2015;	  Takahashi	  et	  al.,	  2016;	  Cantarelli	  et	  al.,	  2017).	  To	  date,	  the	  two	  mainly	  
explored	   options	   are	   xenografts	   and	   stem	   cell-­‐derived	   insulin	   secreting	   cell	   sources,	  
which	   are	  both	  under	   evaluation	   in	  phase	  one	   and	   two	   clinical	   trials	   (Pellegrini	  et	  al.,	  
2016).	  
	  
The	  use	  of	  xenogeneic	  islets,	  in	  particular	  those	  originating	  from	  porcine	  pancreata,	  has	  
been	  studied	  extensively	  and	  stems	  from	  the	  historical	  use	  of	  porcine-­‐derived	  insulin	  to	  
treat	  diabetes	   (Cantarelli	  et	  al.,	   2017).	  Advantages	  of	  using	  porcine	  xenografts	   include	  
the	  large	  size	  of	  the	  porcine	  pancreata,	  resemblance	  between	  porcine	  islets	  and	  human	  
pancreatic	   islets,	   and	   the	   close	   homology	   between	   the	   amino	   acid	   compositions	   of	  
insulin	   from	   both	   species	   (Rother	   &	   Harlan,	   2004;	   Harlan	   et	   al.,	   2009).	   Despite	   its	  
advantages,	  this	  approach	  is	  associated	  with	  various	  safety	  concerns,	  the	  major	  obstacle	  
being	   the	   risk	   of	   transmission	   of	   porcine	   endogenous	   retrovirus	   to	   the	   donors.	   In	  
addition,	   humans	   have	   high-­‐titer	   antibodies	   against	   the	   cell-­‐surface	   galactose-­‐α-­‐1,3-­‐
galactose	  residues	  present	  on	  porcine	  tissue.	  Moreover,	  transplantation	  across	  species,	  
which	   is	   relevant	   in	   terms	   of	   eventual	   human	   in	   vivo	   application,	   requires	   genetic	  
modifications	   to	   render	   porcine	   tissue	   more	   compatible	   and	   prevent	   massive	   and	  
immediate	   graft	   destruction,	   which	   is	   essential	   for	   clinical	   trials	   (Bottino	   &	   Trucco,	  
2015).	  
	  
As	   mentioned,	   other	   investigated	   potential	   candidates	   are	   stem	   cell-­‐derived	   insulin	  
secreting	   cell	   sources,	   particularly	   from	   embryonic	   stem	   cells,	   which	   are	   pluripotent	  
stem	  cells	  derived	  from	  the	  inner	  cell	  mass	  of	  a	  blastocyst,	  and	  induced	  pluripotent	  stem	  
(iPS)	   cells,	   which	   are	   generated	   by	   reprogramming	   somatic	   cells	   (Takahashi	   et	   al.,	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challenges.	  First	  of	  all,	   it	  should	  be	  mentioned	  that	  there	  is	  high	  controversy	  regarding	  
the	   ethical	   concerns	   around	   the	   use	   of	   embryonic	   stem	   cells	   for	   research	   purposes,	  
which	  are	  obviated	  by	  using	  iPS	  cells	  (Pellegrini	  et	  al.,	  2016).	  A	  more	  general	  concern	  is	  
related	  to	  the	  intrinsic	  characteristics	  of	  stem	  cells;	  the	  difficulty	  to	  predict	  and	  control	  
their	   behaviour,	   which	   could	   result	   in	   teratoma	   formation,	   with	   has	   the	   potential	   for	  
malignancy.	  Whereas	  stem	  cell-­‐derived	   insulin	  secreting	  cell	   sources	  do	  offer	  hope	   for	  
cell	   replacement	   therapy,	   substantial	   scientific	   unknowns	   remain	   to	   be	   investigated	  
(McCall	  et	  al.,	  2009).	  	  
	  
Regardless	   of	   the	   (potential)	   alternative	   cell	   source,	   a	   key	   challenge	   is	   to	   overcome	  
immune-­‐mediated	  destruction	  of	  these	  cells.	  One	  popular	  approach	  to	  address	  this	  is	  by	  
introducing	   a	   physical	   barrier	   between	   transplanted	   cells	   and	   the	   recipient.	   Over	   the	  
past	   years,	   a	   variety	   of	   different	   cell	   encapsulation	   strategies	   have	   been	   developed,	  
which	  can	  be	  divided	   into	  microencapsulation	  and	  macroencapsulation	   (Desai	  &	  Shea,	  
2016).	  Whereas	  microencapsulation	   refers	   to	  microscale	   capsules	  which	   house	   single	  
islets,	  macroscale	   encapsulation	   involves	   co-­‐encapsulation	  of	  multiple	   islets,	   the	   latter	  
offering	   enhanced	   control	   over	   encapsulation	   material,	   but	   potentially	   limited	   by	  
inadequate	  diffusion	  from	  and	  towards	  the	  islets.	  	  
	  
5.2.	  Biomaterials	  
One	  of	  most	  extensively	  investigated	  classes	  of	  biomaterials	  for	  TERM	  applications	  are	  
hydrogels.	   Hydrogels	   are	   3D	   networks	   consisting	   of	   hydrophilic	   polymer	   chains	  
(Slaughter	   et	   al.,	   2009;	   Murphy	   et	   al.,	   2013).	   Their	   tuneable	   physicochemical	   and	  
biological	   properties,	   high	   biocompatibility,	   and	   similarity	   to	   the	   native	   extracellular	  
matrix	   make	   them	   a	   promising	   class	   of	   materials	   for	   a	   wide	   range	   of	   biomedical	  
applications.	  	  
	  
Whereas	   there	   is	   currently	  no	   consensus	  on	   the	   ideal	  material	   for	   islet	   encapsulation,	  
alginate	  is	  the	  most	  commonly	  used	  candidate.	  Alginate	  is	  a	  naturally	  occurring	  anionic	  
polysaccharide	   that	   can	   be	   harvested	   from	   brown	   seaweed.	   This	   linear	   unbranched	  
copolymer	   consists	   of	   β-­‐d-­‐mannuronic	   acid	   (M)	   and	   α-­‐l-­‐guluronic	   acid	   (G)	   residues,	  
which	   are	   arranged	   in	   homopolymeric	   blocks	   (i.e.	  MMMM,	   GGGG)	   or	   heteropolymeric	  
blocks	  (i.e.	  GMGM)	  (Augst	  et	  al.,	  2006;	  Zimmermann	  et	  al.,	  2007;	  Lee	  &	  Mooney,	  2012;	  
Pawar	  &	  Edgar,	  2012).	  Among	   the	  different	  available	   crosslinking	  methods,	   the	  use	  of	  
ionic	   cross-­‐linking	   agents,	   such	   as	   divalent	   cations	   (e.g.	  Ca2+)	   is	  most	   frequently	   used	  
(Lee	  &	  Mooney,	  2012).	  These	  cations	  bind	  to	  the	  G-­‐blocks	  present	  in	  the	  alginate	  chains,	  
which	  then	  form	  junctions	  with	  G-­‐blocks	  in	  adjacent	  alginate	  chains,	  also	  referred	  to	  as	  
the	   egg-­‐box	   model.	   However,	   a	   drawback	   of	   this	   approach	   is	   the	   lack	   of	   controlled	  
gelation,	  which	  is	  crucial	  to	  ensure	  gel	  uniformity	  and	  strength.	  Another	  limiting	  factor	  
is	  the	  lack	  of	  long-­‐term	  stability	  in	  physiological	  conditions	  due	  to	  the	  interchange	  of	  the	  
divalent	   ions	   with	   monovalent	   cations	   from	   the	   surrounding	   media.	   Moreover,	   when	  
aiming	   for	   tissue	   engineering	   applications,	   it	   is	   often	   desirable	   to	   modify	   alginate.	  
Alginate	  itself	  lacks	  mammalian	  cell-­‐adhering	  moieties,	  which	  limits	  cell	  attachment	  and	  
regulation,	   making	   this	   biomaterial	   relatively	   bioinert.	   One	   manner	   to	   mediate	   and	  
regulate	   cell	   adhesion	   is	   by	   coupling	   adhesion	   molecules	   (e.g.	   collagen)	   or	   shorter	  
peptides	  to	   the	  alginate	  backbone,	  such	  as	  arginine-­‐glycine-­‐aspartic	  acid	  (RGD)	  (Lee	  &	  
Mooney,	   2012;	   Ahadian	   et	   al.,	   2015).	   Although	   commercially	   available	   alginate	   is	  
derived	  from	  seaweed,	  it	  is	  important	  to	  note	  that	  the	  copolymer	  composition,	  sequence,	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these	   characteristics	   influence	   the	   viscosity	   of	   the	   alginate	   solution	   and	   overall	   gel	  
stiffness	  after	  crosslinking.	  
	  
5.3.	  Bioactive	  molecules	  
As	  may	  be	  evident,	  for	  successful	  implementation,	  TERM	  approaches	  greatly	  rely	  on	  the	  
used	   cell	   types	   and	   biomaterials.	   However,	   beta	   cell	   regulation	   is	   a	   complex	  
orchestration,	   involving	   controlled	   coordination	   of	   mechanical	   and	   biochemical	   cues	  
(Assmann	   et	   al.,	   2009).	   Inspired	   by	   these	   physiological	   events,	   complementary	  
approaches	   such	   as	   the	   enrichment	   of	   grafts	   with	   bioactive	   molecules	   (e.g	   growth	  
factors)	  have	  emerged.	  Although	  beyond	  the	  scope	  of	  this	  thesis,	  as	  described	  in	  detail	  
by	   Assmann	   et	   al.	   (2009),	   various	   key	   regulators	   of	   islet/beta	   cell	   growth,	   cell	  
replication,	   and	   cell	   regeneration	   have	   been	   identified.	   It	   is	   important	   to	   realize	   that	  
designing	   and	   fabricating	   a	   suitable	   and	   functioning	   pancreatic-­‐like	   modality	  
encompasses	  a	  broad	  variety	  of	  factors	  and	  their	  intricate	  interactions	  (Lee	  et	  al.,	  2011).	  
Including	   bioactive	   molecules	   such	   as	   growth	   factors,	   even	   though	   it	   adds	   to	   the	  
complexity	   of	   the	   approach,	   offers	   a	   promising	   means	   to	   enhance	   the	   pancreatic	  





6.1.	  General	  concept	  
TERM	  strategies	  provide	  the	  target	  tissues	  with	  a	  (temporary)	  microenvironment	  and,	  
thereby,	   contribute	   to	   spatio-­‐temporal	   cell	   signalling,	   cell	   identity,	   and	   cell	   function.	  
However,	  accurately	  recapitulating	  the	  complex	  nature	  of	  tissues	  by	  means	  of	  traditional	  
TERM	   approaches	   remains	   challenging,	   especially	  when	   it	   comes	   to	   achieving	   precise	  
architectural	  configurations	  and	  spatial	  positioning	  of	  (multiple)	  cells	  and	  biomaterials.	  
To	  this	  end,	  the	  field	  of	  biofabrication	  offers	  a	  promising	  toolbox	  (Melchels	  et	  al.,	  2012;	  
Malda	  et	  al.,	   2013).	   Combining	  biomaterials,	   cells,	   and	   growth	   factors	  with	   automated	  
fabrication	  processes	  such	  as	  additive	  manufacturing,	  which	  refers	  to	  the	  generation	  of	  
3D	   constructs	   in	   a	   layer-­‐by-­‐layer	   manner	   based	   on	   a	   computer-­‐aided	   design	   (CAD),	  
facilitates	  the	  generation	  of	  3D	  bio-­‐engineered	  constructs	  with	  a	  superior	  organization,	  
resembling	   native	   tissue	   more	   closely.	   Although	   a	   wide	   variety	   of	   additive	  
(bio)manufacturing/biofabrication	   technologies	   have	   been	   described	   in	   the	   literature,	  
three	  main	  categories	  can	  be	  distinguished;	   laser-­‐assisted	  printing,	   inkjet	  printing,	  and	  
extrusion-­‐based	  printing	  (figure	  2)	  (Murphy	  &	  Atala,	  2014).	  	  
	  
	  
Figure	   2.	   Main	   biofabrication	   technologies:	   (A)	   Laser-­‐assisted	   printing,	   (B)	   Inkjet	   printing,	   and	   (C)	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As	  the	  name	  indicates,	  laser-­‐assisted	  printing	  encompasses	  a	  plethora	  of	  manufacturing	  
technologies	  which	  utilize	  a	  laser	  to	  deposit	  (biological)	  materials	  on	  a	  substrate.	  Laser-­‐
assisted	   bioprinting	   stems	   from	   the	   principles	   of	   a	   subclass	   of	   laser-­‐assisted	   printing,	  
namely	  laser-­‐induced	  forward	  transfer	  (LIFT)	  (figure	  2A).	  In	  LIFT	  approaches,	  a	  focused	  
laser-­‐source	   is	   used	   to	   transfer	   material	   from	   a	   so-­‐called	   donor	   slide	   towards	   the	  
receiving	  substrate.	  Typically	   the	  donor	  slide	   is	  covered	  with	  a	   laser	  energy	  absorbing	  
layer	   and	   the	   desired	   (bio)ink.	   The	   focused	   laser	   pulse	   causes	   evaporation	   of	   the	  
absorbing	   layer,	   leading	   to	   the	   formation	   a	   high-­‐pressure	   bubble,	   which	   induces	  
propulsion	  of	  the	  material.	  As	  this	  approach	  is	  nozzle	  free,	  the	  clogging	  issue	  associated	  
with	   inkjet-­‐based	  printing	  or	  extrusion-­‐based	  printing,	  which	  will	  be	  described	  below,	  
are	   overcome.	   In	   addition,	   laser-­‐assisted	   printing	   is	   compatible	  with	  materials	  with	   a	  
broad	   range	   of	   viscosities	   (1–300	   mPa/s)	   and	   able	   to	   deposit	   cells	   at	   medium	   cell	  
density	  (i.e.	  108	  cells/ml)	  (Malda	  et	  al.,	  2013;	  Murphy	  &	  Atala,	  2014;	  Hölzl	  et	  al.,	  2016).	  
Despite	   these	   advantages,	   the	   presence	   of	  metallic	   residues	   in	   the	   final	   construct,	   the	  
challenging	  and	   time-­‐consuming	  nature	  of	  preparing	   individual	   ribbons,	  and	  relatively	  
high	  costs	  are	  several	  examples	  of	  hurdles	  yet	  to	  clear.	  
	  
Inkjet	   printing	   can	   be	   described	   as	   a	   noncontact	   printing	   process	   in	  which	   controlled	  
volumes	  of	  (bio)ink	  (1–100	  picolitres;	  10–50	  μm	  diameter)	  are	  dispensed	  on	  predefined	  
locations,	  driven	  by	   thermal	  or	  piezoelectric	   forces	   (figure	  2B).	  Both	   in	   thermal	   inkjet	  
printing	  and	  piezoelectric	  inkjet	  printing	  bioink	  droplets	  are	  forced	  from	  the	  nozzle	  by	  
means	   of	   creating	   a	   pressure	   pulse.	   In	   thermal	   inkjet	   printing,	   this	   pressure	   pulse	   is	  
generated	   by	   heating.	   This	   heating	   results	   in	   vaporization	   of	   small	   volumes	   of	   the	  
(bio)ink,	  producing	   the	  pulse	  required	   to	  expel	  material	   from	  the	  nozzle.	  Piezoelectric	  
inkjet	   printing	   involves	   the	   application	   of	   a	   direct	   mechanical	   pulse	   to	   the	   (bio)ink,	  
which	   on	   its	   turn	   generates	   the	   pressure	   needed	   to	   force	  material	   though	   the	   nozzle.	  
Regardless	   of	   the	   high	   resolution,	   relatively	   low	   cost,	   and	   wide	   availability	   of	   inkjet	  
printing,	   several	   factors	   impede	   its	   successful	   widespread	   application	   (Malda	   et	   al.,	  
2013;	   Hölzl	   et	   al.,	   2016).	   These	   include	   the	   low	   upper	   viscosity	   limit	   of	   the	   (bio)ink	  
(ideally	   <	   10	   mPa/s),	   the	   potential	   risks	   of	   exposing	   of	   the	   (bio)ink	   to	   thermal	   and	  
mechanical	   stress,	   inconsistency	   in	   droplet	   size,	   and	   nozzle	   clogging	   when	   using	  
biologically	  relevant	  cell	  densities	  (>106	  cells/ml).	  
	  
Nowadays,	  most	  of	  the	  commercially	  available	  bioprinters	  are	  based	  on	  extrusion-­‐based	  
dispensing	  (figure	  2C).	  These	  systems	  function	  by	  robotically	  controlled	  extrusion	  of	  the	  
(bio)ink,	  which	  is	  usually	  driven	  by	  mechanical	  action	  (piston	  or	  screw)	  or	  a	  pneumatic	  
system,	  each	  posing	  their	  own	  (dis)advantages.	  Whereas	  mechanically	  driven	  deposition	  
usually	  provides	  more	  control	  over	  the	  material	  flow,	  pneumatic	  systems	  have	  simpler	  
drive-­‐mechanism	   components,	   the	   latter	   allowing	   for	   higher	   maximum	   force	  
capabilities.	   In	   contrast	   to	   inkjet	   printers,	   which	   yield	   single	   droplets	   of	   material,	  
extrusion	   printers	   yield	   continuous	   filaments	   of	   the	   (bio)material,	   usually	   with	   a	  
resolution	   in	   the	   order	   of	   200	   µm.	   Besides,	   extrusion	   printing	   is	   compatible	   with	  
materials	   with	   a	   wide	   range	   of	   viscosities	   (30	   –	   6×107	   mPa/s).	   	   Even	   though	   its	  
resolution	   is	   substantially	   lower	   compared	   to	   laser-­‐	   or	   inkjet-­‐based	   systems,	   the	  
fabrication	  speed,	  clinically	  relevant	  sizes,	  and	  ability	  to	  deposit	  high	  cell	  densities	  (>108	  
cells/ml)	   make	   this	   technology	   very	   promising	   for	   TERM	   applications	   (Malda	   et	   al.,	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6.2.	  Co-­‐axial	  printing	  
Over	  the	  years,	  all	  kinds	  of	  variations	  on	  traditional	  3D	  printing	  have	  emerged,	  all	  with	  
the	  aim	  to	  develop	  the	  best-­‐suited	  system	  for	  specific	  applications.	  One	  example	   is	  the	  
concept	  of	  co-­‐axial	  extrusion	  printing.	  As	  the	  name	  indicates,	  this	  approach	  involves	  co-­‐
extrusion	   of	   (when	   desired)	  multiple	  materials	   along	   the	   same	   axis.	   Seen	   from	  TERM	  
and	   bioengineering	   perspectives,	   these	   geometries	   have	   the	   advantage	   that	   more	  
delicate	   components	   (e.g.	   cells)	   can	   be	   strategically	   placed	   within	   the	   core	   of	   a	  
surrounding	  protective	  layer,	  the	  latter	  often	  also	  referred	  to	  as	  the	  shell	  (Cathal	  et	  al.,	  
2016).	   Moreover,	   this	   core-­‐shell	   structure	   facilitates	   direct	   compartmentalization	   by	  
means	   of	   (concurrent)	   multi-­‐material	   deposition,	   each	   optimized	   for	   its	   distinctive	  
function	  within	  the	  final	  construct.	  	  
	  
One	   example	  of	   a	   co-­‐axial	   printing	   approach	   is	   presented	  by	  Gao	  et	  al.	  (2015).	   In	   this	  
study,	   hollow	   alginate	   filaments	   were	   created	   for	   nutrient	   delivery.	   A	   cell-­‐laden	   (i.e.	  
mouse	   fibroblasts)	   sodium	   alginate	   solution	   and	   calcium	   chloride	   solution	   were	  
extruded	   through	   the	   shell	   and	   core	   of	   the	   coaxial	   nozzle	   respectively.	   By	   careful	  
selection	   of	   concentration	   and	   flow	   rate	   of	   the	   two	   solutions,	   hollow	   sodium	   alginate	  
filaments	  were	  obtained.	  Crosslinking	  from	  the	  inside	  resulted	  in	  constructs	  which	  were	  
fully	  gelled	   from	  this	  side	  and	  weakly	  gelled	  or	   from	  the	  outside,	   the	   latter	   facilitating	  
crosslinking	  with	  adjacent	   layers	  and	   thereby	   the	   formation	  of	   the	  3D	  construct.	  After	  
fabrication,	  the	  entire	  construct	  was	  immersed	  in	  calcium	  chloride	  solution	  in	  order	  to	  
complete	  crosslinking.	  Standard	  LIVE/DEAD	  viability	  assays	  confirmed	  biocompatibility	  
of	   the	   printing	   method	   and	   enhanced	   cell	   survival	   of	   constructs	   with	   the	   built-­‐in	  
microchannels.	   Other	   examples	   are,	   but	   not	   limited	   to,	   co-­‐axial	   melt	   extrusion	   of	  
hydrogel/thermoplastic	  hybrid	   structures	  by	  Cornock	  et	  al.	   (2014),	  more	   recently,	   co-­‐	  
axial	  extrusion	  of	  biopolymer	  for	  cartilage	  tissue	  engineering	  by	  Costantini	  et	  al.	  (2016),	  
and	  co-­‐axial	  plotting	  of	  polymer	  blends	  with	  the	  aim	  of	  creating	  a	  vascular	  networks	  by	  
Jia	  et	  al.	   (2016).	  Over	  the	  years,	  different	   tools	   to	   facilitate	  co-­‐axial	  printing	  have	  been	  
developed,	  ranging	  from	  relatively	  simple	  co-­‐axial	  print	  heads	  to	  complete	  devices.	  One	  
example	   is	   the	   BioPen,	   a	   device	   capable	   of	   co-­‐axial	   handheld	   printing,	   which	   will	   be	  
explored	  at	  later	  stages	  of	  this	  project	  (O'Connell	  et	  al.,	  2016).	  
	  
6.3.	  Biofabrication	  for	  pancreatic	  purposes	  	  
Regarding	  pancreatic	  application,	  biofabrication	   is	  still	   in	   its	   infancy	  (Yue	  et	  al.,	  2016).	  
To	  our	  knowledge,	  excluding	  the	  printing-­‐based	  tissue	  engineering	  approach	  by	  Daoud	  
et	  al.	   (2011),	   only	   one	   actual	   biofabrication	   study	   has	   been	   reported	   (Marchioli	  et	  al.,	  
2015).	  In	  this	  study,	  3D	  alginate-­‐based	  islet-­‐laden	  (i.e.	  INS1E)	  hydrogel	  constructs	  were	  
bioplotted	   and	   assessed	   in	   terms	   of	   printability,	   glucose	   diffusion,	   cell	   viability,	   and	  
metabolic	   activity	   (Figure	   3A).	   Although	   various	   alginate/extracellular	   matrix	  
components	   blends	   had	   been	   successfully	   prepared	   and	   plotted,	   the	   4|5%	   w/v	  
alginate|gelatin	  composition	  seemed	  most	  suitable	  when	  taking	  printing	  performances,	  
cell	   viability	   (i.e.	   ~95%	   cell	   viability	   on	   day	   21),	   and	   cell	   morphology	   into	   account.	  
However,	   the	  viscous	  nature	  and	  dense	  mesh	  size	  of	   the	  hydrogel	   seemed	   to	  diminish	  
metabolic	   activity	   and	   cell	   functionality,	   which	   was	   most	   likely	   due	   to	   hampered	  
nutrient	   diffusion.	   This	   observation	   was	   further	   illustrated	   by	   glucose	   diffusion	  
measurements,	   which	   demonstrated	   a	   significant	   lag	   time	   before	   reaching	   the	   steady	  
state	  condition	  and	  a	  low	  diffusion	  coefficient	  (i.e.	  1.13	  ×	  10-­‐6	  cm2	  s−1).	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was	  based	  on	  inducing	  angiogenesis.	  Macroporous	  polycaprolactone	  (PCL)	  ring-­‐shaped	  
scaffolds	   were	   plotted	   and	   subsequently	   coated	   with	   heparin,	   which	   showed	   to	   be	   a	  
simple	   strategy	   for	   delivery	   of	   VEGF	   (Figure	   3B).	   Human	   islets	   of	   Langerhans	   were	  
encapsulated	   in	   a	   2%	   w/v	   alginate	   hydrogel	   and	   contained	   in	   the	   open	   core	   of	   the	  
heparinised	  PCL	  ring	   (~20	   islets	  per	   scaffold).	  The	  neovascularization	  potential	  of	   the	  
scaffolds	  with	  VEGF	  was	  tested	  using	  a	  chicken	  chorioallanthoic	  membrane	  (CAM)	  assay,	  
which	  demonstrated	  induction	  of	  neovascularization.	  Noteworthy,	  different	  blood	  vessel	  
morphologies	  were	   observed	   among	   different	   VEGF	   concentrations,	   the	  most	   optimal	  
concentration	   found	   to	   be	   200	   ng.	   To	   investigate	   the	   potential	   improvement	   of	  
vascularization	   of	   the	   fabricated	   constructs,	   the	   migration	   of	   human	   umbilical	   vein	  
endothelial	   cells	   (HUVECs)	   towards	   the	   scaffold	   was	   assessed.	   Although	   increased	  
migration	   was	   detected	   towards	   heparin-­‐coated	   scaffolds	   compared	   to	   non-­‐coated	  
scaffolds,	   this	   behaviour	   did	   not	   seem	   to	   depend	   on	   increasing	   VEGF	   concentrations.	  
Overall,	   islet	  cells	  showed	  to	  be	  responsive	  to	  glucose	  stimulation	  and	  cell	  viability	  did	  
not	  seem	  to	  be	  affected	  by	  the	  experimental	  procedure.	  	  
	  
	  
Figure	   3.	   (Bio)printing	   strategies	   for	   bioartificial	   pancreas.	   Left:	   Plotting	   schematic	   and	   plotted	  
alginate/gelatin	   scaffolds	   (scale	   bar	   1	   cm).	   Right:	   Cartoon	   of	   hybrid	   scaffold	   concept;	   heparinised	   PCL	  
rings	   surrounding	   islet	   encapsulating	   alginate	   hydrogels.	   Figures	  modified	   from	  Marchioli	   et	  al.	   (2015)	  
and	  Marchioli	  et	  al.	  (2016).	  
	  
7.	  Project:	  The	  concept	  
As	   sketched	   in	   the	   previous	   sections,	   the	   current	   approach	   to	   pancreatic	   islet	  
transplantation	   is	   still	   associated	   with	   substantial	   drawbacks	   (Ryan	   et	   al.,	   2005;	  
Vaithilingam	   &	   Tuch,	   2011;	   McCall	   &	   Shapiro,	   2012).	   In	   this	   work,	   a	   solution	   to	   this	  
problem	  is	  pursued	  by	  means	  of	  a	  biofabrication	  approach.	  By	  combining	  the	  power	  of	  
biofabrication	   technology	  and	  advanced	  biomaterial	  knowledge,	   this	  work	  exploits	   the	  
potential	  to	  better	  recapitulate	  the	  native	  in	  vivo	  environment	  and	  advance	  (pancreatic)	  
tissue	  engineering	  and	  current	  diabetes	  care.	  The	  aim	  of	  this	  study	  is	  to	  fabricate	  grid-­‐
like	  3D	  core-­‐	  shell	  constructs,	  which	  house	  both	  pancreatic	  beta	  and	  endothelial	  cells	  in	  
one	   construct.	   By	   carefully	   tuning	   the	   geometry	   of	   the	   construct,	   we	   envision	   to	  






14	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
conditions.	   To	   realize	   this,	   a	   dual	   material	   coaxial	   fabrication	   approach	   is	   proposed	  
(Figure	  4).	  This	  strategy	  provides	  a	  two-­‐fold	  advantage:	  1)	  multiple	  relevant	  cell	   types	  
(i.e.	  beta	  cells	  and	  endothelial	   cells)	  are	  contained	   throughout	  one	  construct,	  yet	   in	  an	  
environment	   optimized	   for	   each	   individual	   cell	   type	   and	   2)	   this	   core-­‐shell	   structure	  
holds	   the	   potential	   to	   offer	   immuno-­‐protection,	   the	   another	  major	   factor	   limiting	   the	  
islet	   transplantation	  procedure.	  At	   this	  stage,	   the	   focus	   is	  put	  on	  the	  development	  of	  a	  
relevant	  bioink	  formulation	  to	  fabricate	  bioartificial	  vascularized	  pancreatic	  constructs.	  
	  
The	  context:	  when	  starting	  the	  project,	  hydrogel	  discs	  (i.e.	  2%|3.3%	  w/v	  alginate|gelatin)	  
had	  just	  been	  implanted	  subcutaneously	  in	  C57BL/6	  mice.	  Two	  week	  post-­‐transplantation,	  
no	  signs	  of	  the	  constructs	  were	  detected,	  indicating	  insufficient	  stability,	  given	  the	  fact	  that	  
the	   process	   of	   vascularization	   takes	   ~2	  weeks	   (Menger	   et	   al.,	   2001;	  Morini	   et	   al.,	   2007;	  
Brissova	  &	  Powers,	  2008).	  
	  
To	   stay	   in	   line	   with	   the	   original	   formulation,	   it	   was	   chosen	   to	   switch	   to	   an	  
alginate|gelatin-­‐methacryloyl	   (GelMA)	   blend	   as	   a	   starting	   material.	   Whereas	   pure	  
gelatin	   forms	   thermo-­‐reversible	   hydrogels	   via	   physical	   interactions	   between	   the	  
molecules,	   GelMA	   can	   undergo	   photo-­‐initiated	   polymerization	   via	   the	   (mainly)	  
methacrylamide	  side-­‐groups,	  resulting	  in	  covalently	  crosslinked	  hydrogels.	  As	  being	  the	  
hydrolysis	   product	   of	   collagen,	   gelatin	   retains	   the	   bioactive	   sequences	   present	   in	  
collagen	  (e.g.	  the	  RGD	  peptide,	  matrix	  metalloproteinase	  sequences),	  which	  are	  involved	  
in	   cell	   adhesion	   and	   matrix	   remodelling	   (Van	   den	   Steen	   et	   al.,	   2002).	   Given	   that	   the	  
chemical	   modification	   usually	   comprises	   less	   than	   5%	   of	   the	   amino	   acid	   residues	   in	  
molar	   ratio,	   the	  majority	   of	   these	   sequences	  will	   not	   be	   affected	   by	   this	  modification	  
(Yue	  et	  al.,	  2015).	  By	  combining	  the	  inherent	  bioactivity	  of	  gelatin	  with	  the	  tailorability	  
of	   photo-­‐crosslinking,	   and	   enhanced	   viscous	   properties	   when	   adding	   alginate,	   the	  
alginate|GelMA	   blend	   base-­‐material	   is	   expected	   to	   meet	   both	   biofunctionality	   and	  




Figure	  4.	  Schematic	  representation	  of	  the	  proposed	  co-­‐axial	  printing	  approach	  to	  establish	  vascularized	  
bioarticfical	   pancreatic	   constructs.	   	   Pancreatic	   insulin	   secreting	   cells	   will	   be	   housed	   in	   the	   core	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8.	  Materials	  and	  methods	  
	  
8.1.	  Material	  preparation	  	  
GelMA	  was	  prepared	  by	  a	  direct	  reaction	  of	  gelatin	  [porcine	  skin,	  Type	  A,	  ~175g	  Bloom	  
or	   300g	   Bloom,	   Sigma-­‐Aldrich]	   with	   methacrylic	   anhydride	   [MW=154.16,	   Sigma-­‐
Aldrich].	   Prior	   to	   initiating	   the	   reaction,	   gelatin	   powder	   was	   sterilized	   by	   20	   min	  
exposure	  to	  UV	  light	   in	  a	   laminar	  flow	  hood	  [RFC	  cabinet,	  AES	  environmental].	  Gelatin	  
was	   dissolved	   in	   phosphate	   buffered	   saline	   (PBS)	   and	   mixed	   for	   one	   hour	   at	   40°C,	  
resulting	   in	  a	  10%	  w/v	  gelatin	  solution.	  While	  vigorously	  stirring	  and	  after	   increasing	  
the	  temperature	  to	  50°C,	  methacrylic	  anhydride	  was	  added	  to	  the	  gelatin	  solution	   in	  a	  
drop-­‐wise	  manner	  (final	  concentration:	  7.4%	  v/v).	  The	  reaction	  was	  allowed	  to	  continue	  
for	  3	  hours,	  after	  which	  the	  reaction	  was	  terminated	  by	  diluting	  the	  solution	  four	  times	  
with	   PBS	   (o/n).	   After	   adding	   1%	   v/v	   of	   chloroform,	   the	   solution	   was	   thoroughly	  
dialyzed	  against	  distilled	  water	  for	  seven	  days	  at	  40°C	  (cellulose	  membrane,	  MW	  cut-­‐off:	  
~12	   kDa).	   Finally,	   the	   dialyzed	   GelMA	   solution	  was	   lyophilized	   to	  white	   porous	   foam	  
[Martin	  Christ,	  ALPHA	  2-­‐4	  LDplus]	  and	  stored	  at	  -­‐20	  °C	  until	  further	  use.	  Polymer	  blends	  
were	  prepared	  by	  supplementing	  alginate	  [moderate	  viscosity,	  Sigma-­‐Aldrich]	  solutions	  
(in	  PBS)	  with	  the	  appropriate	  amount	  of	  GelMA	  (i.e.	  physical	  blending).	  	  
	  
8.2.	  In	  vitro	  degradation	  
To	   assess	   in	   vitro	   degradation	   of	   the	   alginate|GelMA	   interpenetrating	   network,	   a	  
degradation	   assay	  by	  means	  of	   polymer	  dry	  weight	  was	  performed.	  Both	  2|7.5%	  w/v	  
alginate|GelMA	  and	  2|10%	  w/v	  alginate|GelMA	  solutions	  in	  PBS	  (n=3)	  containing	  0.06%	  
w/v	   	   lithium	   phenyl-­‐2,4,6-­‐trimethylbenzoylphosphinate	   (LAP)	   photoinitiator	   were	  
prepared	  and	  injected	  into	  custom-­‐made	  cylindrical	  molds	  (~8	  mm	  in	  diameter	  by	  1	  mm	  
in	  height).	  The	  solutions	  were	  crosslinked	  with	  visible	  light	  [Omnicure,	  BVL-­‐4.LC,	  output	  
15-­‐30%,	  λ	  =	  400	  nm]*	  for	  1	  minute,	  followed	  by	  crosslinking	  with	  2%	  w/v	  CaCl2	  solution	  
for	  10	  minutes.	  After	  o/n	  incubation	  at	  standard	  cell	  culture	  conditions	  (humidified,	  37	  
°C,	   5%	   CO2)	   in	   complete	   MS1	   culture	   medium,	   the	   constructs	   were	   lyophilized	   o/n	  
[Martin	  Christ,	  ALPHA	  2-­‐4	  LDplus]	  and	  subsequently	  weighed,	  which	  revealed	   the	  dry	  
weight	  at	  time	  point	  zero	  (WdT0).	  The	  lyophilized	  constructs	  were	  incubated	  at	  standard	  
cell	   culture	   conditions	   for	   21	   days	   in	   complete	   MS1	   culture	   medium,	   with	   medium	  
changes	  performed	  every	   three	   to	   four	  days.	  On	  day	  1,	  4,	  7,	  14	  and	  21,	   the	  constructs	  
were	   lyophilized	  and	  weighed	  as	  described	  above,	   revealing	   the	  dry	  weight	  over	   time.	  
The	  degradation	  was	  determined	  by	  means	  of	  the	  following	  equation,	  where	  WdTx	  refers	  
to	  the	  polymer	  weight	  at	  the	  specified	  time	  points:	  
	  
(WdT0	  −	  WdTx)/	  WdT0	  ×	  100	  
	  
*Initially,	  the	  intensity	  of	  the	  light	  source	  was	  measured	  with	  the	  wrong	  sensor	  (i.e.	  λ=	  365	  nm	  detection).	  
Whereas	  an	  appropriate	  sensor	  was	  used	  at	  later	  stages,	  this	  sensor	  failed	  to	  detect	  low	  input	  values.	  As	  
described	  by	  van	  Kogelenberg	  (2017),	  one	  possible	  method	  to	  account	  for	  this,	  is	  by	  means	  of	  extrapolation	  
from	  higher	  input	  values.	  However,	  given	  the	  controversy	  on	  the	  reliability	  of	  this	  method,	  it	  was	  chosen	  to	  
refer	  to	  the	  machine	  settings,	  ensuring	  reproducibility	  of	  the	  approach.	  
	  	  
8.3.	  Rheological	  characterization	  
To	   support	   macroscopic	   observations	   and	   predict	   printing	   behaviour	   of	   the	   polymer	  
blend	   once	   extruded	   from	   the	   BioPen,	   a	   rheological	   characterization	   was	   performed	  
using	   an	   AR	   G-­‐2	   rheometer	   [TA-­‐Instruments]	   either	   fitted	   with	   plate-­‐plate	   geometry	  






16	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
angle:	   2°;	   gap:	   55	   μm).	   All	   tests	  were	   performed	   in	   triplicate	   and	   the	   presented	   data	  
represents	   the	   mean	   of	   each	   test	   with	   corresponding	   standard	   deviation.	   Selected	  
samples	  (i.e.	  2|5%	  w/v,	  2|7.5%	  w/v,	  and,	  2|10%	  w/v	  alginate|GelMA)	  were	  stored	  at	  -­‐
20°C	  and	  thawed	  in	  a	  37°C	  water	  bath	  30	  minutes	  prior	  to	  experimentation.	  
	  
To	   probe	   the	   temperature	   responsiveness	   of	   the	   polymer	   blends,	   oscillatory	  
temperature	   sweeps	  were	  performed.	  Samples	  were	   subjected	   to	  a	   temperature	   ramp	  
from	   4°C-­‐40°C,	   with	   a	   constant	   heating	   rate	   of	   1.5	   °C/min.	   Measurements	   were	  
performed	   at	   an	   oscillation	   frequency	   of	   1	   Hz	   and	   1%	   strain.	   After	   this	   scan,	   it	   was	  
decided	   to	   perform	   all	   consecutive	   experiments	   at	   both	   15°C	   and	   23°C,	   which	  
correspond	   to	   the	   observed	   optimal	   temperatures	   for	   filament	   deposition	   and	   room	  
temperature	  respectively.	  In	  order	  to	  evaluate	  the	  influence	  of	  the	  chosen	  experimental	  
parameters,	   oscillatory	   time	   (25	   minutes),	   strain	   (0.1-­‐100%	   strain),	   and	   frequency	  
sweeps	  were	  performed	  (0.1-­‐100	  Hz).	  During	  all	  these	  tests,	  the	  storage	  moduli	  (G’)	  and	  
loss	   moduli	   (G”)	   were	   recorded.	   Unless	   stated	   otherwise,	   measurements	   were	  
performed	  at	  1	  Hz	  and	  1%	  strain.	   In	  addition,	  viscosity	  measurements	  as	  a	   function	  of	  
shear	  rate	   (shear	  rate	  range	  =	  0.1-­‐100	  s-­‐1;	  equilibration	   time:	  1	  min)	  were	  performed.	  
Finally,	   to	   evaluate	   the	  material	   responses	   to	   stress	   and	   to	   determine	   the	   yield	   point,	  
continuous	  flow	  experiments	  were	  performed	  with	  linearly	  ramped	  stress	  rates	  (range	  
stress	  rates	  =	  0.1-­‐1000	  Pa).	  	  
	  
8.4.	  Cell	  lines	  and	  culture	  conditions	  	  
Mouse	  pancreatic	  Beta-­‐TC-­‐6	  beta	   cells	   and	  MILE	  SVEN	  1	   (MS1)	   endothelial	   cells	  were	  
obtained	  from	  American	  Type	  Culture	  Collection	  (ATCC).	  Beta-­‐TC-­‐6	  cells	  were	  cultured	  
in	  high-­‐glucose	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  (DMEM)	  [+L-­‐glutamine,	  +	  sodium-­‐	  
pyruvate,	   +	   pyridoxine	   hydrochloride,	   Life	   Technologies],	   prepared	   according	   to	  
manufacturer’s	  instructions.	  This	  culture	  medium	  was	  further	  supplemented	  with	  15%	  
v/v	  fetal	  bovine	  serum	  (FBS)	  [Life	  Technologies],	  1%	  v/v	  50:50	  penicillin:streptomycin	  
[Life	  Technologies],	  1%	  v/v	  glutamax	  [200mM,	  Life	  Technologies],	  and	  0.0005%	  v/v	  β-­‐	  
mercaptoethanol	   (ThermoFisher).	   MS1	   cells	   were	   cultured	   in	   above-­‐mentioned	   high	  
glucose	   DMEM,	   further	   supplemented	   with	   5%	   v/v	   FBS,	   1%	   v/v	   50:50	  
penicillin:streptomycin,	   and	   1%	   v/v	   glutamax.	   Both	   cell	   types	   were	   maintained	   at	  
standard	   cell	   culture	   conditions	   and	   passaged	   1:3	   and	   1:8	   for	   Beta-­‐TC-­‐6	   and	   MS1	  
endothelial	  cells	  respectively	  when	  ~80%	  confluence	  was	  reached.	  
	  
8.5.	  Murine	  islet	  isolation	  and	  culture	  conditions**	  	  
Pancreatic	  islets	  were	  isolated	  from	  ten	  male	  six-­‐week	  old	  C57BL/6	  mice	  [University	  of	  
Adelaide	  Laboratory	  Animal	  Services,	  SA,	  Australia].	  In	  brief,	  each	  pancreas	  was	  inflated	  
by	   injecting	  3	  mL	   cold	  M199	  medium	   [Sigma-­‐Aldrich]	   containing	  0.67	  mg	   collagenase	  
[Liberase	   TL	   grade,	   Roche]	   into	   the	   pancreatic	   duct	   in	   situ.	   After	   full	   inflation,	   the	  
pancreas	  was	  dissected	  from	  the	  surrounding	  tissue	  and	  digested	  at	  37°C	  for	  9	  minutes.	  
Islets	  were	  purified	  from	  pancreatic	  acinar	  tissue	  on	  a	  discontinuous	  Ficoll	  gradient	  [GE	  
Healthcare,	  Buckinghamshire,	  United	  Kingdom].	  Purified	  islets	  were	  counted	  and	  hand-­‐
picked	  for	  subsequent	  experiments.	  The	  procedure	  was	  approved	  by	  the	  Animal	  Ethics	  
Committee	  of	  the	  University	  of	  Adelaide	  and	  in	  accordance	  with	  the	  Australian	  Code	  of	  
Practice	  for	  the	  Care	  and	  Use	  of	  Animals	  for	  Scientific	  Purposes.	  
	  
**Islet	  isolation	  performed	  by	  D.	  Penko	  and	  K.	  Kang	  during	  visit	  at	  Royal	  Adelaide	  Hospital	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To	  examine	  the	  influence	  of	  cell	  encapsulation	  and	  the	  crosslinking	  conditions	  on	  Beta-­‐
TC-­‐6,	   MS1,	   and	   islet	   cell	   viability,	   standard	   LIVE/DEAD	   assays	   were	   performed	  
[ThermoFisher	   Scientific].	   Beta-­‐TC-­‐6	   and	   MS1	   cells	   were	   separately	   encapsulated	   in	  
2|7.5%	   w/v	   and	   2|10%	   w/v	   alginate|GelMA	   solutions	   containing	   0.06%	   v/v	   LAP	  
photoinitiator,	  yielding	  a	  concentration	  of	  2×106	  cells/mL.	  The	  cell-­‐laden	  solutions	  were	  
injected	   into	   above-­‐mentioned	   custom-­‐made	   molds	   and	   subsequently	   crosslinked,	  
resulting	   in	   a	   disc-­‐shaped	   3D	   culture	   environment	   (~8	  mm	   in	   diameter	   by	   1	   mm	   in	  
height).	  Samples	  were	  maintained	  at	  standard	  cell	  culture	  conditions	  until	   further	  use.	  
In	   pilot	   experiments,	   cell	   viability	   was	   assessed	   with	   Fluorescein	   diacetate	  
(FDA)/propidium	  iodide	  (PI),	  which	  stain	  live	  and	  dead	  cells	  respectively.	  FDA	  is	  a	  cell-­‐
permeable	   esterase	   substrate,	   which	   becomes	   fluorescent	   once	   hydrolyzed	   by	  
intracellular	  esterases	  active	  in	  living	  cells.	  PI	  is	  a	  cell-­‐impermeable	  agent,	  which	  cannot	  
pass	  through	  a	  viable	  uncompromised	  cell	  membrane.	  Upon	  loss	  of	  membrane	  activity,	  
PI	   enters	   the	   cell	   and	  binds	   to	  DNA	  by	   intercalating	  between	   the	  bases,	   increasing	   its	  
fluorescence.	  FDA	  solution	  was	  added	  to	  the	  samples	  at	  a	  final	  concentration	  of	  10	  mM	  
and	  incubated	  at	  at	  standard	  cell	  culture	  conditions	  for	  5	  minutes.	  Subsequently,	  PI	  was	  
added	  at	   a	   final	   concentration	  5	  μg/mL	  and	   incubated	   for	   another	  2	  minutes	   at	   room	  
temperature.	  For	  both	  cell	   types,	  cell	  viability	  assessed	  on	  day	  0	  (i.e.	  immediately	  after	  
encapsulation)	  and	  after	  1,	  3,	  5	  and	  7	  days	  of	   culture.	  Later	  on,	  MS1	  cell	   viability	  was	  
assessed	  over	  a	  period	  of	  21	  days	  with	  calcein-­‐AM	  and	  PI	  [ThermoFisher],	  which	  has	  a	  
similar	   mode	   of	   action	   as	   FDA/PI.	   Calcein-­‐AM	   was	   added	   to	   the	   samples	   at	   a	   final	  
concentration	   of	   5	   mM	   and	   incubated	   at	   at	   standard	   cell	   culture	   conditions	   for	   20	  
minutes.	   PI	  was	   added	   at	   a	   final	   concentration	   1	   μg/mL	   and	   incubated	   for	   another	   5	  
minutes	  at	  standard	  cell	  culture	  conditions.	  	  
	  
To	  assess	  the	  effect	  of	  cell	  encapsulation	  and	  crosslinking	  conditions	  on	  primary	  islets,	  
500	  primary	  islets/mL	  were	  encapsulated	  in	  2|7.5%	  w/v	  alginate|GelMA.	  The	  solutions	  
were	  injected	  into	  custom-­‐made	  molds	  and	  subsequently	  crosslinked,	  resulting	  in	  a	  disc-­‐
shaped	   3D	   culture	   environment	   (~4	   mm	   in	   diameter	   by	   1	   mm	   in	   height).	   Both	   the	  
constructs	   and	   control	   samples	   (i.e.	  ~100	   purified	   islets	   maintained	   as	   free-­‐floating	  
cultures)	  were	  kept	   in	  Roswell	  Park	  Memorial	   Institute	   (RPMI)	  1640	  medium	   [Sigma-­‐
Aldrich]	   supplemented	  with	   10%	  v/v	   fetal	   calf	   serum	   (FCS),	   1%	  v/v	   L-­‐glutamine,	   1%	  
w/v	   penicillin,	   1%	   v/v	   streptomycin,	   at	   standard	   cell	   culture	   conditions	   until	   further	  
use.	   Cell	   viability	   was	   assessed	   after	   24	   hours	   in	   culture	   by	   means	   of	   FDA/PI	   as	  
described	  above.	  	  
	  
Cell	   viability	  was	   estimated	  by	  using	   fluorescence	  microscopy	   [ZEISS	  Axiovert	   40	  CFL	  
inverted	  microscope].	   Excitation	   and	   emission	  were	   set	   to	   488/530	   nm	   and	   530/580	  
nm	   to	   detect	   green	   and	   red	   fluorescently	   labeled	   cells	   respectively	   and	   three	   random	  
fields	  were	  imaged	  for	  each	  sample.	  To	  determine	  cell	  viability,	  the	  number	  of	  living	  and	  
dead	   Beta-­‐TC-­‐6	   and	   MS1	   cells	   were	   counted	   using	   ImageJ	   software.	  Regarding	   the	  
primary	   islets,	   cell	   viability	   was	   estimated	   based	   on	   the	   ratio	   between	   the	   numbers	  
living	  and	  dead	  cells	  in	  the	  islet.	  
	  
8.7.	  MS1	  metabolic	  activity	  	  
To	   complement	   the	   LIVE/DEAD	   cell	   viability	   assays	   and	   to	   quantify	   the	   proliferation	  
activity	   of	   MS1	   cells	   over	   time,	   PrestoBlue	   assays	   were	   performed	   according	   to	  
manufacturer’s	   protocol	   [ThermoFisher].	   This	   assay	   is	   based	   on	   a	   cell-­‐permeable	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resazurin	   to	   resorufin,	   a	   fluorescent	   compound	   which	   can	   be	   detected	   either	  
fluorometrically	  or	  spectrophotometrically.	  	  MS1-­‐laden	  (passage	  6)	  hydrogel	  discs	  were	  
prepared	  and	  maintained	  as	  described	  in	  section	  8.6	  and	  monitored	  over	  a	  period	  of	  21	  
days.	  Medium	  changes	  were	  performed	  every	  2-­‐3	  days.	  On	  day	  0,	  1,	  4,	  7,	  14,	  and	  21	  the	  
constructs	  were	  transferred	  to	  fresh	  complete	  culture	  medium	  supplemented	  with	  10%	  
v/v	   10x	   PrestoBlue.	   After	   1	   hour	   incubation	   at	   standard	   cell	   culture	   conditions,	   the	  
constructs	  were	  removed	  from	  the	  wells,	  the	  medium	  was	  aliquoted	  to	  a	  96-­‐well	  plate,	  
and	   fluorescence	   was	   monitored	   at	   544	   nm	   (excitation)	   and	   590	   nm	   (emission)	  
[POLARstar	  Omega	  microplate	  reader].	  After	  reading,	  the	  constructs	  were	  rinsed	  three	  
times	  with	  complete	  culture	  medium	  and	  incubated	  at	  standard	  cell	  culture	  conditions	  
until	   further	   analysis.	   As	   a	   background	   control,	   cell-­‐free	   hydrogels	  were	   included.	   To	  
account	  for	  cells	  leaking	  from	  the	  gels,	  the	  PrestoBlue	  assay	  was	  also	  performed	  on	  the	  
remaining	   medium	   in	   the	   initial	   well-­‐plate.	   This	   culture	   medium	   was	   directly	  
supplemented	  with	  10%	  v/v	  10x	  PrestoBlue	  reagent	  and	  incubated	  for	  thirty	  minutes	  at	  
standard	  cell	  culture	  conditions.	  Plain	  MS1	  complete	  culture	  medium	  was	  included	  as	  a	  
background	  control.	  To	  quantify	  the	  amount	  of	  cells	  leaking	  from	  the	  gels,	  the	  obtained	  
fluorescence	   was	   compared	   against	   a	   calibration	   curve	   composed	   of	   known	   cell	  
numbers	   (i.e.	   5×103	   -­‐	   4×105	  cells/well).	   The	   obtained	   data	  was	   analysed	   according	   to	  
manufacturer’s	  protocol	  and	  represents	  the	  average	  of	  the	  background	  corrected	  values	  
(n=3	  per	  condition).	  
	  
8.8.	  Scanning	  Electron	  Microscopy	  (SEM)	  
To	   investigate	   the	  microstructure	  of	  2|7.5%	  w/v	  and	  2|10%	  w/v	  alginate|GelMA,	  bulk	  
hydrogel	   constructs	   were	   imaged	   using	   low	   vacuum	   SEM	   [GATAN	  MonoCL4	   system].	  
Hydrogel	   discs	  were	   prepared	   as	   described	   in	   section	   8.2.	   and	   incubated	   in	   complete	  
MS1	  culture	  medium	  at	  standard	  cell	  culture	  conditions	  until	  analysis.	  The	  first	  images	  
were	  collected	  two	  hours	  after	  preparation.	  Swollen	  hydrogels	  were	  cut	  in	  half	  to	  expose	  
their	   cross-­‐sectional	   area	   and	   frozen	   with	   liquid	   nitrogen	   for	   45	   seconds	   prior	   to	  
imaging.	   2%	  w/v	   alginate	   and	   7.5%	  w/v	   GelMA	   samples	   were	   taken	   into	   account	   to	  
compare	  the	  porosity	  and	  morphology	  of	  pure	  and	  blend	  hydrogels.	  To	  investigate	  the	  
microstructure	   of	   2|7.5	   w/v	   alginate|GelMA	   over	   time,	   additional	   SEM	   images	   were	  
taken	  after	  8	  and	  15	  days	  in	  culture.	  	  
	  
	  
9.	  Results	  and	  discussion	  
	  
9.1.	  Material	  selection	  
Adoption	  and	  long-­‐term	  success	  of	  TERM	  and	  biofabrication	  approaches	  greatly	  rely	  on	  
the	   bioinks	   being	   used.	   These	   bioinks	   should	   not	   only	   suffice	   in	   terms	   of	   printing	  
properties,	  but	  also	  in	  terms	  of	  biocompatibility.	  An	  ideal	  bioink	  poses	  the	  appropriate	  
mechanical	  properties,	  while	  providing	  a	  favourable	  microenvironment	  for	  the	  cells;	  an	  
environment	   that	   supports	   cellular	   functions	   such	   as	   cell	   growth,	   migration,	  
differentiation,	  and	  proliferation.	  As	  described	  in	  detail,	  both	  alginate	  and	  gelatin/GelMA	  
have	  already	  shown	  to	  be	  valuable	  biomaterials	   for	  TERM	  approaches	  (Lee	  &	  Mooney,	  
2012;	  Klotz	  et	  al.,	  2016).	  For	  this	  reason,	  and	  to	  stay	  in	  line	  with	  previously	  performed	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A	  range	  of	  different	  alginate|GelMA	  polymer	  blends	  were	  prepared,	   from	  which	  a	  pre-­‐
selection	   was	   made	   based	   on	   two	   criteria:	   1)	   the	   ability	   to	   form	   a	   homogenous	  
suspension	  and	  2)	  the	  apparent	  viscosity,	  which	  are	  both	  important	  factors	  for	  extrusion	  
bioprinting.	  As	  described	  by	  Cohen	  et	  al.	  (2011)	  and	  Dubbin	  et	  al.	  (2016),	  heterogeneity	  
in	  bioink	  formulations	  can	  cause	  local	  variation	  in	  the	  material	  properties,	  which	  could	  
lead	   to	   inconsistent	   printing	   quality,	   nozzle	   clogging,	   and	   inhomogeneous	   cell	  
distributions.	   As	   may	   be	   evident,	   this	   lack	   of	   uniformity	   does	   not	   only	   increase	   the	  
variability	   within	   a	   given	   print,	   but	   also	   between	   different	   prints.	   Another	   essential	  
factor	   to	   consider	   when	   developing	   a	   bioink	   is	   the	   viscosity,	   which	   refers	   to	   the	  
resistance	  of	  a	   fluid	  to	  flow	  upon	  application	  of	  stress	  (Malda	  et	  al.,	  2013).	  A	  sufficient	  
degree	  of	  viscosity	  could	  prevent	  cell	  settling	  and	  aggregation	  and	  facilitates	  geometry	  
fidelity	  post-­‐printing	  (Ferris	  et	  al.,	  2013).	  	  
	  
Macroscopic	   analysis	   of	   the	   different	   polymer	   blends	   revealed	   that	   higher	   alginate	  
concentrations	  (i.e.	  2%	  w/v)	  correlated	  with	  enhanced	  viscous	  properties.	  This	  is	  in	  line	  
with	   a	   previous	   study	   performed	   by	   Chung	   et	   al.	   (2013),	   who	   demonstrated	   that	   an	  
increase	   in	   alginate	   concentration	   resulted	   in	   an	   increase	   in	   gelatin/alginate	   bioink	  
viscosity.	  However,	  it	  was	  found	  that	  blending	  these	  higher	  alginate	  concentrations	  with	  
GelMA	  derived	  from	  high	  molecular	  weight	  gelatin	  (~300	  g	  Bloom)	  led	  to	  macroscopic	  
phase-­‐separation	   (table	   1).	   More	   detailed,	   when	   blending	   the	   two	   polymer	   solutions	  
together,	  an	  opaque	  gel	  precipitate	  and	  a	  clear	  solution	  component	  became	  apparent.	  As	  
described	   by	   Panouille	   &	   Larreta-­‐Garde	   (2009),	   this	   phase	   separation	   is	   a	   commonly	  
described	   phenomenon	   in	   biopolymer	   blends	   (i.e.	   protein	   and/or	   polysaccharide).	  
Regarding	  our	  alginate|GelMA	  blend,	  this	  complexation	  is	  most	   likely	  to	  stem	  from	  the	  
interactions	   between	   the	   oppositely	   charged	   molecules.	   Whereas	   alginate	   carries	   a	  
global	  negative	   charge,	  GelMA	  (derived	   from	   type	  A	  gelatin	   in	   this	   study)	  has	  a	  global	  
positive	  net	  charge,	  resulting	  in	  electrostatic	  interaction.	  Other	  factors,	  such	  as	  hydrogen	  
bonding,	  Van	  der	  Waals	  forces,	  and	  hydrophobic	  interaction,	  may	  also	  contribute	  to	  the	  
intermolecular	   interactions,	   collectively	   determining	   the	   stability	   of	   the	   polymer	  
network.	   Since	   these	   intermolecular	   interactions	   can	   be	   regulated	   by	   varying	   the	  
polymer	   molecular	   weight,	   it	   was	   decided	   to	   explore	   GelMA	   obtained	   from	   medium	  
molecular	  weight	   gelatin	   (~175	   g	   Bloom).	   By	   switching	   to	   GelMA	   prepared	   from	   this	  
lower	   molecular	   weight	   gelatin,	   a	   range	   of	   alginate|GelMA	   polymer	   blends	   were	  
developed	   in	   the	   absence	   of	  macroscopic	   aqueous-­‐phase	   phase-­‐separation.	   It	  must	   be	  
noted	   that	   blending	   these	   polymers	   together	   resulted	   in	   an	   overall	   cloudy	   structure,	  
which	   most	   likely	   stems	   from	   nano-­‐or	   microscopic	   phase-­‐separation	   (i.e.	   non-­‐	  
macroscopic	  phase-­‐separation).	  
	  
Taken	   the	   above-­‐mentioned	   considerations	   into	   account,	   it	   was	   chosen	   to	   continue	  
subsequent	   experiments	  with	  GelMA	  obtained	   from	  medium	  molecular	  weight	   gelatin	  
(~175	  g	  Bloom),	  with	   concentrations	   ranging	   from	  5%-­‐10%	  w/v	   in	   combination	  with	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Table	  1.	  Macroscopic	  assessment	  of	  alginate|GelMA	  blends	  in	  terms	  of	  homogeneity	  and	  viscosity.	  
	  
	   GelMA	  (high	  mol.	  weight,	  ~300	  g	  Bloom)	  
	  




































































































9.2.	  In	  vitro	  degradation	  assessment	  
Formulating	   a	   bioink	   is	   still	   rather	   challenging	   and	   involves	   careful	   consideration	   of	  
multiple	   factors,	   one	   example	   being	   the	   degradation	   properties	   of	   the	   material(s).	  
Ideally,	   the	   selected	   (composite)	   biomaterial	   allows	   matrix	   remodelling	   and/or	  
degradation,	  while	  ensuring	  sufficient	  durability	  for	  tissue	  development	  and	  maturation,	  
which	   depends	   on	   the	   desired	   application.	   Controlling	   polymer	   concentrations	   and	  
adjusting	  crosslinking	  parameters	  (e.g.	  degree	  of	  methacrylation,	  duration	  and	  intensity	  
of	   crosslinking)	   could	  easily	   tailor	   the	  mechanical	  properties	  and	  durability.	  However,	  
the	  resulting	  dense	  polymer	  networks	  may	  not	  be	  appropriate	  in	  terms	  of	  maintaining	  
cell	   viability	   and/or	   function	   (Kong	   et	   al.,	   2003;	  Marchioli	   et	   al.	   2015).	   As	   previously	  
mentioned,	  for	  the	  purpose	  of	  this	  study,	  a	  material	  which	  would	  be	  stable	  for	  a	  period	  
of	  28	  days	  was	  desired.	  	  
	  
To	   assess	   the	   stability	   of	   the	   proposed	   alginate|GelMA	   hydrogel	  materials,	   an	   in	   vitro	  
degradation	   assay	   was	   performed.	   	   2|5%	   w/v,	   2|7.5%	   w/v,	   and	   2|10%	   w/v	  
alginate|GelMA	  hydrogel	  blends	  were	  prepared	  as	  described	  above	  and	  macroscopically	  
inspected	  over	   time.	  Constructs	  were	  considered	   to	  be	  stable	   if	   the	  discs	  were	  easy	   to	  
handle	  (i.e.	  transfer	  and	  lift	  with	  spatula)	  and	  maintained	  their	  disc-­‐shaped	  morphology	  
for	  at	  least	  28	  days.	  
	  
This	  pilot	  experiment	  revealed	  that	  the	  stability	  of	  the	  constructs	  increased	  with	  higher	  
GelMA	  concentrations.	  Whereas	  discs	  obtained	   from	  relatively	  weakly	   crosslinked	   (i.e.	  
crosslinking	   output:	   15%)	   2|5%	   w/v	   alginate|GelMA	   were	   already	   partially	  
disintegrated	  on	  day	  5,	  all	  constructs	  lost	  their	  disc-­‐shape	  morphology	  at	  day	  9	  (figure	  
S1).	  Even	   though	  the	  most	  weakly	  crosslinked	  2|7.5%	  w/v	  alginate|GelMA	  blend	  discs	  
have	   shown	   to	   be	  more	   durable,	   only	   the	  more	   strongly	   crosslinked	   (i.e.	  output	   light	  
source:	   30%)	   2|7.5%	   w/v	   alginate|GelMA	   blend	   constructs	   retained	   their	   disc-­‐shape	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2|10%	   w/v	   alginate|GelMA	   (i.e.	   output	   light	   source:	   15%)	   was	   durable	   for	   28	   days,	  
indicating	  that	  this	  blend	  could	  serve	  as	  a	  potential	  candidate.	  These	  observations	  are	  in	  
accordance	  with	   previous	   findings,	   demonstrating	   that	   lower	   polymer	   concentrations	  
result	  in	  faster	  hydrogel	  degradation/dissolution	  rates	  (Aparnathi	  &	  Patel,	  2016).	  	  
	  
To	   quantify	   our	   observations,	   a	   degradation	   assay	   by	   means	   of	   loss	   of	   polymer	   dry	  
weight	   was	   performed.	   Since	   the	   pilot	   experiment	   demonstrated	   that	   2|5%	   w/v	  
alginate|GelMA	   did	   not	   suffice	   in	   terms	   of	   durability,	   it	   was	   decided	   to	   exclude	   this	  
condition	  from	  further	  study.	  Given	  the	  detrimental	  effect	  of	  cell	  encapsulation	  in	  2|10%	  
w/v	  alginate|GelMA	  on	  Beta-­‐TC-­‐6	  cell	  viability,	  as	  will	  be	  described	  below	  in	  section	  8.4,	  
it	   was	   chosen	   to	   focus	   on	   2|7.5%	   w/v	   alginate|GelMA.	   As	   shown	   in	   figure	   5,	   the	  
constructs	  remained	  stable	  over	  a	  period	  of	  2	  weeks	   in	  vitro,	  which	  was	  in	  accordance	  
with	  the	  observations	  from	  the	  pilot	  experiment.	  
	  
	  
Figure	   5.	   Degradation	   of	   2|7.5	   %	   w/v	   alginate|GelMA	   by	   means	   of	   polymer	   dry	   weight.	   Polymer	   dry	  
weight	  remained	  constant	  over	  a	  period	  over	  21	  days.	  Data	  is	  presented	  in	  mean±sd	  (n=3).	  
	  
In	   order	   to	   gain	   a	   better	   understanding	   of	   this	   alginate|GelMA	   polymer	   blend	   and	  
predict	   its	   in	  vivo	   behaviour,	   it	   is	   essential	   to	   understand	   the	   degradation/dissolution	  
process	  of	  both	  individual	  polymers.	  Since	  mammals	  lack	  the	  enzyme	  that	  can	  cleave	  the	  
alginate	   polymer	   chain,	   alginate	   is	   inherently	   non-­‐degradable	   by	   mammals	   (Lee	   &	  
Mooney,	   2012).	   However,	   it	   is	   known	   that	   in	   vitro	   calcium-­‐crosslinked	   alginate	  
hydrogels	  readily	  lose	  their	  mechanical	  properties,	  which	  occurs	  through	  the	  exchange	  
of	  the	  cross-­‐linking	  cations	  with	  monovalent	  cations	  present	  in	  the	  surrounding	  media	  
(Chung	  et	  al.,	  2013).	  Dissolution	  in	  physiological	  conditions	  is	  most	  likely	  driven	  by	  the	  
gradual	  diffusion	  of	  calcium	  ions	  out	  of	  the	  matrix	  and	  the	  sensitivity	  of	  the	  hydrogels	  to	  
calcium	   chelating	   compounds	   such	   as	   phosphate,	   citrate,	   and	   lactate	   (Shoichet	   et	   al.,	  
1996;	   Boontheekul	   et	   al.,	   2005).	   Degradation	   of	   GelMA	   is	   largely	   dependent	   on	   local	  
degradation	   by	   enzymes,	   in	   particular	   matrix	   metalloproteinases.	   These	   enzymes	   are	  
secreted	   by	   (embedded)	   cells	   and	   have	   the	   ability	   to	   degrade	   extracellular	   matrix	  
components	   (van	   den	   Steen	   et	   al.,	   2008;	   Klotz	   et	   al.,	   2016).	   Given	   the	   nature	   of	   this	  
experiment	   (i.e.	   in	   vitro,	   in	   absence	   of	   active	   enzymatic	   degradation),	   it	   is	   therefore	  
expected	  that	  placing	  the	  construct	  in	  a	  more	  relevant	  environment,	  could	  influence	  the	  
results.	   It	   is	   suggested	   to	   repeat	   the	   experiment	   with	   cell-­‐laden	   constructs	   and	  
preferably	   in	   a	   relevant	   in	  vivo	  environment.	   In	   addition,	   it	   should	   be	  mentioned	   that	  
working	   with	   these	   small	   volumes	   and	   polymer	   weights,	   makes	   this	   approach	   fairly	  
susceptible	   to	   misinterpretation.	   Even	   though	   the	   procedure	   was	   performed	   as	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calibration	   of	   the	   scale	   could	   interfere	   with	   the	   results.	   To	   complement	   the	   current	  
approach,	  it	  is	  therefore	  recommended	  to	  perform	  an	  active	  degradation	  experiment,	  in	  
which	   the	   hydrogel	   constructs	   would	   be	   prepared	   and	   maintained	   as	   described,	   but	  
exposed	  to	  active	  enzymatic	  degradation.	  	  
	  
Although	   less	   literature	   is	   available	   on	   the	   degradation	   and	   interaction	   of	  
alginate|GelMA	  hydrogels,	   it	   is	  noteworthy	  that	  several	  studies	  have	  shown	  synergistic	  
effects	  in	  terms	  of	  viscous	  properties	  (Jia	  et	  al.,	  2016;	  Kadri	  et	  al.,	  2016).	  
	  
9.3.	  Rheological	  evaluation	  
As	   for	  most	   polymers,	   hydrogels	   exhibit	   visco-­‐elastic	   behaviour,	   indicating	   that	   these	  
materials	  exhibit	  both	  viscous	  and	  elastic	  characteristics	  when	  undergoing	  deformation.	  
Whereas	   purely	   elastic	   materials	   deform	   (within	   limits)	   in	   proportion	   to	   the	   applied	  
force	  and	  return	  to	  their	  original	  state	  after	  removal	  of	  this	  force,	  visco-­‐elastic	  materials	  
hold	   a	   viscous	   component	   to	   the	   response,	   which	   means	   that	   the	   load-­‐deformation	  
relationship	   is	   time-­‐dependent.	  As	   suggested	  by	  Zhao	  et	  al.	   (2015),	   this	   viscoelasticity	  
seems	  to	  be	  a	  key	  determinant	  for	  printability	  and	  cell	  viability.	  	  
	  
Essential	  parameters	  to	  understand	  when	  performing	  rheological	  measurements	  are	  the	  
storage	  modulus	   G’,	  which	   describes	   the	   elastic	   properties	   of	   a	  material,	   and	   the	   loss	  
modulus	  G’’,	  which	  describes	  the	  viscous	  properties	  of	  the	  material.	  When	  G’	  dominates,	  
a	  material	  can	  be	  described	  as	  an	  elastic	  gel.	  Similarly,	  when	  G’’	  dominates,	  the	  material	  
behaves	  as	  a	  viscous	  liquid.	  As	  described	  by	  Chung	  et	  al.	  (2013),	  for	  printing	  purposes,	  
ideally	   the	   bioink	   should	   exhibit	   gel-­‐like	   characteristics.	   In	   addition,	   both	  Chung	  et	  al.	  
(2013)	  and	  Zhao	  et	  al.	   (2015)	  have	  shown	   that	  G’	  of	  ~200	  Pa	   is	   required	  high-­‐fidelity	  
cell	  printing	  of	  cell-­‐encapsulating	  alginate/gelatin	  bioinks.	  
	  
Given	   that	   the	   current	   BioPen	   design	   does	   not	   include	   any	  mechanism	   to	   control	   the	  
temperature,	   a	   bioink	   formulation	   that	   would	   allow	   accurate	   printing	   and	   shape	  
maintenance	  at	  room	  temperature	  (~23	  °C)	  is	  pursued.	  To	  study	  the	  thermal	  behaviour	  
of	  our	  inks,	  temperature	  sweeps	  were	  performed	  for	  2|5%	  w/v,	  2|7.5%	  w/v,	  and	  2|10%	  
w/v	  alginate|GelMA	  blends.	  As	  illustrated	  in	  figure	  6,	  a	  similar	  overall	  trend	  is	  seen	  for	  
all	   the	   formulations;	  both	   the	  G’	   and	  G’’	   are	   relatively	  high	  at	   lower	   temperatures	  and	  
decrease	  dramatically	  with	  increasing	  temperatures,	  which	  is	  in	  line	  with	  the	  thermally	  
reversible	  gelation	  behaviour	  of	  GelMA	  (Kolesky	  et	  al.,	  2014).	  Moreover,	   in	  agreement	  
with	   Zhao	   et	   al.	   (2015),	   it	   was	   shown	   that	   an	   increase	   in	   polymer	   concentration	   is	  
correlated	  with	  an	  increase	  in	  the	  moduli.	  
	  
When	   looking	   at	   the	   G’	   values	   at	   room	   temperature,	   regardless	   of	   the	   polymer	  
concentration,	   these	   values	   seem	   to	   be	   insufficient	   for	   accurate	   printing	   (i.e.	   2|5%	  
w/v=44.2±7.0	   Pa,	   2|7.5%	   w/v=60.6±9.3	   Pa,	   2|10%	   w/v=77.6±28.6	   Pa).	   At	   a	   lower	  
temperature	  of	  15˚C,	  G’	  values	  rise	  to	  202.1±23.5	  Pa,	  550.7±47.4	  Pa,	  and	  984.0±25.9	  Pa	  
for	  2|5%	  w/v,	  2|7.5%	  w/v,	  and	  2|10%	  w/v	  alginate|GelMA	  respectively.	  Together,	  these	  
results	   indicate	  that	  all	  polymer	  blends	  seem	  promising	  for	  extrusion	  with	  the	  BioPen,	  
given	   that	   the	   inks	  will	  be	  cooled	  prior	   to	  use	  or	  once	  extruded.	  As	  mentioned	  before,	  
keeping	   both	   these	   results	   and	   the	   degradation	   experiment	   in	  mind,	   it	  was	   chosen	   to	  
exclude	  the	  2|5%	  w/v	  polymer	  blend	  from	  further	  rheological	  experiments.	  In	  addition,	  
it	   is	   important	   to	   realize	   that	   the	   results	   obtained	   from	   this	   experiment	   are	   quite	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are,	   at	   least	   partly,	   sensitive	   to	   factors	   such	   as	   sample	   preparation,	   handling,	   and	  
loading,	  testing	  parameters,	  and	  the	  chosen	  machine-­‐related	  parameters.	  	  
	  
	  
Figure	   6.	   Temperature	   sweeps	   of	   (A)	   2|5%	  w/v,	   (B)	   2|7.5%	  w/v,	   and	   (C)	   2|10%	  w/v	   alginate|GelMA	  
samples	  and	  (D)	  corresponding	  storage	  moduli	  (G’).	  Data	  is	  presented	  in	  mean±sd	  (n=3).	  
	  
As	   described	   by	   Zuidema	   et	   al.	   (2013),	   results	   obtained	   from	   these	   rheological	  
experiments	   greatly	   rely	   on	   the	   chosen	   experimental	   parameters.	   To	   assess	   possible	  
interference	  of	  the	  experimental	  parameters	  with	  the	  results,	  frequency,	  time,	  and	  strain	  
dependence	  of	  the	  moduli	  were	  examined.	  As	  can	  been	  appreciated	  from	  figure	  S2,	  the	  
chosen	  strain	  parameter	  (i.e.	  1%	  strain)	  seems	  to	  be	  in	  the	  (most)	  linear	  region	  of	  each	  
of	   the	   graphs,	   indicating	   that	   obtained	   results	   are	   not	   likely	   to	   be	   influenced	   by	   this	  
experimental	  strain	  setup.	  However,	  when	  looking	  figure	  S3,	  G’	  and	  G’	  keep	  rising	  with	  
increasing	  frequency.	  These	  graphs	  indicate	  that	  frequency-­‐depended	  influences	  cannot	  
be	   completely	   excluded	   from	   the	   results.	   Therefore,	   it	   is	   suggested	   to	   repeat	   the	  
rheological	  measurements	  at	  a	  higher	  frequency.	  As	  can	  be	  appreciated	  from	  figure	  S4,	  
the	   time	   sweep,	   stability	   was	   reached	   in	   ~10	   minutes,	   suggesting	   that	   the	   observed	  
effects	  in	  the	  previously	  mentioned	  strain	  and	  frequency	  sweeps	  are	  likely	  to	  stem	  from	  
these	   respective	   independent	   variables,	   rather	   than	   time-­‐dependent	   influences	   on	   the	  
bioink.	  Noteworthy	  is	  the	  increase	  in	  G’	  and	  its	  persistent	  dominance	  for	  all	  formulations	  
upon	   lowering	   the	   temperature	   to	   15˚C.	   This	   is	   consistent	   with	   the	   formation	   of	   an	  
elastic	   gel-­‐like	   network	   at	   this	   temperature,	   indicating	   that	   this	   would	   be	   a	   suitable	  
temperature	  for	  printing.	  	  
	  
As	  is	  illustrated	  in	  figure	  7,	  the	  viscosity	  of	  the	  formulations	  was	  found	  to	  correlate	  with	  
the	  polymer	  concentration.	  As	  polymer	  concentrations	  rise,	  an	  increase	  in	  viscosity	  was	  
observed.	  In	  addition,	  all	  samples	  demonstrated	  a	  decrease	  in	  viscosity	  with	  increasing	  
shear	  rate,	   indicating	  shear-­‐thinning	  behaviour.	  From	  a	  biofabrication	  perspective,	  this	  
behaviour	   has	   several	   advantages.	   Upon	   extrusion	   from	   the	   nozzle,	   the	   bioink	  will	   be	  
subjected	   to	  shear	   forces.	  These	  shear	   forces	  will,	   in	  case	  of	  shear-­‐thinning	  behaviour,	  
result	  in	  a	  drop	  in	  viscosity,	  which	  will	  facilitate	  the	  deposition	  of	  the	  bioink	  and	  reduce	  
nozzle-­‐clogging	   (Carrow	   et	   al.,	   2015).	   Besides	   these	   advantages	   in	   terms	   of	   printing	  
itself,	   it	   has	   been	   shown	   that	   shear-­‐thinning	   has	   a	   positive	   effect	   on	   cell	   survival	   of	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Figure	  7.	   Influence	  of	  shear	  rate	  on	  2|7.5	  and	  2|10%	  w/v	  alginate|GelMA	  polymer	  viscosity.	  Shown	  is	  a	  
decrease	  in	  viscosity	  with	  increasing	  shear	  rates,	   indicating	  shear-­‐thinning	  behavior.	  Data	  is	  presented	  in	  
mean±sd	  (n=3).	  	  
	  
9.4.	  Beta-­‐TC-­‐6	  and	  MS1	  cell	  viability	  
To	  investigate	  which	  of	  the	  alginate|GelMA	  hydrogel	  matrices	  would	  be	  most	  suitable	  to	  
deliver	   pancreatic	   beta	   and	   endothelial	   cells,	   both	   Beta-­‐TC-­‐6	   and	   MS1	   cells	   were	  
encapsulated	  in	  2|7/5%	  w/v	  and	  2|10%	  w/v	  alginate|GelMA	  and	  assessed	  by	  means	  of	  
an	   FDA/PI	   live	   dead	   assay	   over	   a	   period	   of	   7	   days.	   Beta-­‐TC-­‐6	   cells	   encapsulated	   in	  
2|7/5%	   w/v	   alginate|GelMA	   showed	   83.6%	   cell	   viability	   immediately	   after	  
encapsulation,	  which	  gradually	  decreased	  to	  77.4%	  on	  day	  seven	  (figure	  S5).	  Compared	  
to	  this,	  the	  2|10%	  w/v	  alginate|GelMA	  blend	  and	  crosslinking	  conditions	  showed	  to	  be	  
more	   detrimental	   for	   the	   Beta-­‐TC-­‐6	   cells.	   Whereas	   the	   initial	   cell	   viability	   after	  
encapsulation	  was	  77.7%,	   this	  decreased	  dramatically	   to	  59.9	  %	  on	  day	  3	   (figure	  S5).	  
Based	   on	   these	   results,	   it	   was	   chosen	   to	   focus	   on	   2|7.5	   w/v	   alginate|GelMA	   in	  
subsequent	   experiments.	   Viability	   of	   MS1	   cells	   encapsulated	   in	   2|7/5%	   w/v	  
alginate|GelMA	  dropped	  from	  81.3%	  immediately	  after	  encapsulation	  to	  59.9%	  on	  day	  
3.	   It	  must	  be	  noted	  that	  these	  cell	  viabilities	  were	  substantially	   lower	  compared	  to	  the	  
cell	   viability	   post-­‐harvesting	   from	   the	   culture	   flaks	   (confirmed	   with	   trypan	   blue).	  
However,	   counting	   the	   cells	   during	   routine	   passaging	   also	   revealed	   very	   large	  
inconsistencies	  in	  cell	  viability,	  indicating	  that	  the	  used	  cell	  sources	  might	  not	  have	  been	  
optimal.	  Given	   the	   available	   time,	   it	  was	   chosen	   to	  proceed	  with	   the	   experiments,	   but	  
regard	   these	   results	   solely	   as	   preliminary	   and	   to	   narrow	   down	   conditions	   for	  
subsequent	  experiments.	  Upon	  return	  in	  Wollongong,	  once	  the	  ordered	  cells	  (Beta-­‐TC-­‐6,	  
MS1)	  were	  approved	  for	  use,	  the	  experiments	  were	  repeated	  with	  freshly	  obtained	  cells	  
from	   ATCC.	   Unfortunately,	   we	   did	   not	   manage	   to	   grow	   the	   Beta-­‐TC-­‐6	   cells,	   which	   is	  
mostly	  likely	  to	  stem	  from	  inconsistencies	  in	  the	  pH-­‐level	  of	  pre-­‐made	  base-­‐medium.	  	  
	  
MS1	  cells	  were	  encapsulated	  in	  2|7/5%	  w/v	  alginate|GelMA	  and	  assessed	  by	  means	  of	  a	  
calcein/PI	  live	  dead	  assay	  over	  a	  period	  of	  21	  days.	  As	  may	  be	  appreciated	  from	  figure	  7,	  
the	  cells	  were	  successfully	  encapsulated	  and	  homogeneously	  distributed	  throughout	  the	  
alginate|GelMA	  constructs.	  Calcein/PI	  cell	  viability	  analysis	  demonstrated	  93%	  viability	  
immediately	  after	  encapsulation	  	  and	  95%	  after	  one	  day	  in	  culture,	  which	  was	  similar	  to	  
MS1	  cell	   viability	   after	  harvesting	  and	  prior	   to	  encapsulation	   (~	  96%,	   confirmed	  with	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Whereas	   the	   cells	   were	   initially	   evenly	   distributed	   throughout	   the	   entire	   construct	  
and	   appeared	   as	   single	   rounded	   cells	   inside	   the	   gel,	   the	   first	   signs	   of	   cell	   elongation	  
became	  apparent	  after	  1	  day	  in	  culture	  (figure	  8B).	  On	  day	  4	  clear	  networks	  of	  elongated	  
cells	  were	  noticeable,	   forming	  small	  clusters	   in	  distinct	  areas.	  These	  networks	  became	  
increasingly	   prominent	   and	   dominating	   over	   time,	   indicating	   interaction	   with	   and	  
remodelling	   of	   the	   material	   (Figure	   8C-­‐F).	   Although	   these	   cell	   networks	   cannot	   be	  
accurately	  quantified	  with	  ImageJ,	  hardly	  any	  PI-­‐positive	  cells	  were	  observed	  from	  day	  4	  
onwards.	  Together,	  these	  results	  indicate	  that	  the	  2|7/5%	  w/v	  alginate|GelMA	  hydrogel	  
matrix	   is	   able	   to	   house	   MS1	   cells	   over	   at	   least	   three	   weeks	   in	   culture	   and	   that	   the	  
encapsulation	   and	   crosslinking	   procures	   do	   not	   have	   detrimental	   effects	   on	   MS1	   cell	  
viability.	  	  	  
	  
	  
Figure	   8.	   MS1	   mouse	   pancreatic	   endothelial	   cells	   encapsulated	   in	   2|7.5%	   w/v	   alginate|GelMA	   (A)	  
immediately	  after	  encapsulation	  and	  after	  (B)	  1,	  (C)	  4,	  (D)	  7,	  (E)	  14,	  and	  (F)	  21	  days	  in	  culture	  (scale	  bar	  
200	  μm).	  Calcein/PI	  was	  used	  to	  stain	  alive	  (green)	  and	  dead	  (red)	  cells	  respectively.	  
	  
9.5.	  MS1	  metabolic	  activity	  
To	   assess	   MS1	   cellular	   proliferation	   within	   2|7/5%	   w/v	   alginate|GelMA,	   PrestoBlue	  
assays	   were	   performed	   over	   a	   period	   of	   three	   weeks.	   As	   shown	   in	   figure	   9A,	   the	  
absorbance	   increased	   gradually	   as	   a	   function	   of	   culture	   time,	   indicating	   cellular	  
proliferation	   over	   three	  weeks.	   As	   expected	   and	   in	   accordance	  with	   the	   observations	  
from	   the	   LIVE/DEAD	   assays,	   cells	   were	   present	   in	   the	   surrounding	   medium,	   which	  
indicates	   leaking	   of	   -­‐initially	   encapsulated-­‐	   cells	   from	   the	   hydrogel	   constructs	   (figure	  
8B).	  Based	  on	  the	  calibration	  curve	  composed	  of	  known	  cell	  numbers,	  it	  was	  estimated	  
that	  ~25%	  of	  the	  initially	  encapsulated	  cells	  were	  leaking	  from	  the	  gels	  after	  one	  day	  in	  
culture,	  which	  decreased	  to	  ~10%	  on	  day	  4	  (figure	  9B-­‐D).	  After	  one	  week	  in	  culture,	  a	  
major	  increase	  in	  the	  amount	  of	  cells	  in	  the	  remaining	  medium	  was	  observed.	  However,	  
on	  day	  7,	  macroscopic	  cracks	  were	  visible	  in	  the	  gels,	  which	  are	  thought	  to	  have	  caused	  
this	   relatively	  high	   cell	  number.	  As	  a	   general	  observation	   it	   should	  be	  mentioned	   that	  
the	  hydrogel	  samples	  subjected	  to	  PrestoBlue	  reagent,	  regardless	  of	  being	  cell-­‐laden	  or	  
not,	   seemed	   to	   lose	   their	   integrity	   over	   time.	   Already	   from	   day	   4,	   the	   gels	   became	  
relatively	   pliant	   compared	   to	   the	   same	   batch	   of	   both	   cell-­‐laden	   and	   cell-­‐free	   gels	  
prepared	  for	  parallel	  LIVE/DEAD	  and	  degradation	  experiments	  (figure	  S6),	  which	  made	  
it	  increasingly	  difficult	  to	  handle	  the	  samples.	  	  
	  
Given	   that	   cells	   sense	   and	   respond	   to	   their	   surrounding	   environment,	   in	   this	   case	   the	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in	  intact	  constructs	  (Mason	  et	  al.,	  2012).	  For	  example	  Banerjee	  et	  al.	  (2009)	  have	  shown	  
that	   the	  proliferation	  of	  alginate-­‐encapsulated	  neural	  stem	  cells	   increased	  significantly	  
with	   decreasing	   modulus	   of	   the	   hydrogels.	   In	   line	   with	   this,	   Cavo	   et	   al.	   (2016)	   have	  
demonstrated	   elasticity-­‐mediated	   cellular	   proliferation	   of	   human	   breast	   cancer	   cells	  
(MCF-­‐7)	  encapsulated	   in	  alginate	  hydrogels.	   In	  contrast,	  mesenchymal	   stem	  cells	  have	  
demonstrated	  to	  undergo	  marked	  proliferation	  and	  cell	  spreading	  when	  cultured	  on	  stiff	  
substrates	  compared	  with	  softer	  substrates	  (Marklein	  &	  Burdick,	  2010).	  Even	  though	  to	  
our	  knowledge	  no	  similar	  observations	  have	  not	  been	  reported	  in	  literature,	  nor	  in	  the	  
institute,	  it	  would	  be	  worthwhile	  to	  re-­‐assess	  MS1	  cell	  proliferation	  with	  for	  example	  an	  
AlamarBlue	   assay	   or	   quantitative	   end-­‐point	   assays	   such	   as	  MTT	   or	   PicoGreen	   dsDNA	  
assays	   to	   confirm	   that	   the	   cellular	   proliferation	   is	   not	   affected	   by	   loss	   of	   hydrogel	  
integrity.	  	  
	  
Even	  though	  it	   is	   likely	  that	  the	  relatively	  high	  amount	  of	  cells	   leaking	  from	  the	  gels	   is	  
related	  to	  the	  loss	  of	  integrity	  over	  time	  and	  thereby	  an	  overestimation,	  it	  is	  something	  
that	   should	   be	   carefully	   assessed	   when	   keeping	   the	   final	   goal	   in	   mind.	   Harvesting	  
primary	  islets	  from	  donor	  tissue	  is	  a	  delicate	  and	  time-­‐consuming	  process	  and	  especially	  
when	  taking	  limiting	  factors	  such	  as	  donor	  shortage	  into	  account,	  this	  is	  a	  serious	  point	  
of	  discussion.	  Besides,	  even	  if	  potentially	  unlimited	  supplies	  of	  cells	  for	  transplantation	  
(e.g.	  stem	  cell-­‐derived	  beta-­‐cell	  sources)	  would	  become	  an	  option	  in	  the	  future,	  there	  is	  
abundant	  literature	  reporting	  on	  the	  importance	  of	  amount	  of	  functional	  islets	  is	  key	  for	  
restoring	   normal	   blood	   function,	   which	   once	   more	   illustrates	   the	   importance	   of	  
understanding	  the	  carrier	  system	  and	  how	  the	  system	  might	  change	  over	  time,	  thereby	  
influencing	  the	  (experimental)	  outcome.	  
	  
	  
Figure	  9.	  Effect	  of	  cell	  encapsulation	  on	  MS1	  cell	  proliferation	  measured	  by	  PrestoBlue	  reagent.	  (A)	  Cell	  
proliferation	  of	  MS1	  cells	  encapsulated	  in	  2|7.5%	  w/v/	  alginate|GelMA.	  (B)	  Cell	  proliferation	  of	  MS1	  cells	  
in	  the	  surrounding	  medium.	  (C)	  Cell	  proliferation	  of	  MS1	  cells	  plated	  on	  tissue	  culture	  plastic.	  	  
	  
	  
9.6.	  Primary	  mouse	  islet	  isolation,	  encapsulation,	  and	  viability	  	  
Literature	   is	  abundant	   in	  describing	  protocols	   for	  successful	  pancreatic	   islet	   isolations	  
(Carter	  et	  al.,	  2009).	  As	  discussed,	  retrieving	  pancreatic	  islets	  is	  an	  intricate	  process	  and	  
requires	  careful	  consideration	  of	  a	  plethora	  of	  factors,	  including	  organ	  preparation,	  islet	  
isolation,	   islet	   purification,	   and	   islet	   culture	   post-­‐harvesting,	   which	   all	   come	   with	  
additional	   considerations	   (Carter	   et	   al.,	   2009;	   Bertuzzi	   &	   De	   Carlis,	   2016).	   Obtaining	  
viable	   and	   functional	   islets	   in	   an	   efficient	   manner	   is	   key	   for	   any	   transplantation	  
procedure	  and	  prerequisite	  for	  reliable	  experimental	  outcome.	  	  	  
	  
The	   islet	   isolation	  procedure	  performed	  as	  described	   in	  section	  8.5.	   resulted	   in	  a	   total	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yield	   from	   average	   C57BL/6	   mice	   ranges	   from	   150-­‐250	   islets	   per	   pancreas	   using	   a	  
similar	  protocol	   (Stull	  et	  al.,	   2012).	  Microscopic	   inspection	   immediately	  after	   isolation	  
revealed	  that	  the	  majority	  of	  the	  islets	  were	  in	  a	  good	  state	  after	  isolation	  and	  prior	  to	  
encapsulation;	   the	   islets	   exhibited	   relatively	   smooth	   rounded	   to	   oblong	   surfaces,	  with	  
hardly	   any	   cells	   protruding	   from	   the	   rough	   islet	   surface,	   and	   in	   the	   absence	   of	   dark	  
necrotic	  cores	  (figure	  10)	  (Carter	  et	  al.,	  2009;	  Stull	  et	  al.,	  2012).	  	  
Typically,	   islets	   are	   allowed	   to	   recover	   overnight	   from	   the	   isolation	   process	   before	  
further	  processing	  (Carter	  et	  al.,	  2009).	  However,	  given	  the	  time,	  the	  isolated	  islets	  were	  
immediately	  encapsulated	  in	  the	  2|7.5	  alginate|GelMA	  hydrogel.	  Microscopic	  inspection	  
demonstrated	   successful	   islet	   encapsulation,	   with	   islets	   distributed	   throughout	   the	  
entire	  construct	  (figure	  10).	  	  
	  
	  	  
Figure	  10.	  Mouse	  pancreatic	  islets	  directly	  after	  isolation	  (scale	  bar	  left	  500	  μm,	  right	  200	  μm)	  and	  after	  
encapsulation	  in	  2|7/5%	  w/v	  alginate|GelMA	  (scale	  bar	  500	  μm).	  
	  
Microscopic	  evaluations	  of	  FDA/PI	  stained	  alginate|GelMA-­‐encapsulated	  primary	   islets	  
after	   24	   hours	   in	   culture	   revealed	   only	   a	   small	   number	   of	   PI-­‐permeable	   cells.	   The	  
majority	  of	  cells	  within	  the	  islets	  stained	  positive	  for	  FDA,	  indicating	  the	  cells	  were	  alive	  
(figure	  10).	  Compared	  to	  the	  control,	   free-­‐floating	  islet	  on	  tissue	  culture	  substrates,	  no	  
substantial	   differences	   were	   observed	   (figure	   11).	   These	   results	   indicate	   that	   mouse	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Figure	   11.	   (A)	   Primary	   mouse	   pancreatic	   islets	   24	   hours	   after	   encapsulation	   in	   2|7/5%	   w/v	  
alginate|GelMA	   (scale	   bar	   100	   μm).	   FDA/PI	   was	   used	   to	   stain	   alive	   (green)	   and	   dead	   (red)	   cells	  
respectively.	  (B)	  Primary	  free-­‐floating	  mouse	  pancreatic	  islets	  24	  hours	  after	  isolation	  (scale	  bar	  200	  μm).	  
	  
It	   is	   noteworthy	   that	   this	   experiment	   was	   initially	   planned	   for	   over	   a	   48-­‐hour	   time-­‐
frame.	   However,	   after	   48	   hours	   incubation	   at	   standard	   cell	   culture	   conditions,	   the	  
hydrogel	   started	   losing	   its	   integrity,	  which	   resulted	   in	   termination	   of	   the	   experiment.	  
Whereas	  to	  our	  knowledge	  no	  similar	  cases	  are	  reported	  in	  literature,	  this	  might	  have	  to	  
do	   with	   the	   composition	   of	   the	   RPMI	   medium.	   Especially	   given	   that	   all	   other	  
experiments	  performed	   in	  DMEM	   (degradation,	   LIVE/DEAD	  assays)	   did	  not	   show	  any	  
similar	  effect	  on	  the	  hydrogel	  matrix	  over	  a	  substantially	  longer	  period	  of	  time.	  	  
	  
To	   assess	   gel	   stability	   and	   host	   interaction	   in	   vivo,	   cell-­‐free	   constructs	   will	   be	  
subcutaneously	  implanted	  in	  C57BL/6	  mice.	  At	  the	  moment	  of	  writing,	  the	  samples	  have	  
been	  prepared	  and	  have	  been	  implanted	  at	  the	  Royal	  Adelaide	  Hospital.	  Stability	  of	  the	  
constructs	  will	  be	  assessed	  after	  7	  and	  14	  days	  in	  vivo.	  
	  	  
9.7.	  Hydrogel	  microstructure	  
For	  successful	  long-­‐term	  application,	  it	  is	  important	  to	  provide	  the	  target	  tissues	  with	  a	  
(temporary)	  microenvironment	  that	  mimics	  the	  native	  milieu	  as	  closely	  as	  possible.	  One	  
essential	  design	  consideration	  is	  the	  porosity.	  Adequate	  porosity	  is	  not	  only	  essential	  for	  
uniform	   cell	   distribution,	   cell	   migration,	   and	   cell	   proliferation,	   but	   also	   to	   ensure	  
appropriate	   oxygen,	   nutrients,	   and	  waste	   exchange.	  Besides,	   appropriate	  porosity	   and	  
pore	  interconnectivity	  facilitates	  tissue	  integration	  and	  (neo)vascularization,	  which	  is	  of	  
particular	  importance	  for	  this	  application	  (Chiu	  et	  al.,	  2011).	  
	  
C57BL/6	  islets	  encapsulated	  in	  
2|7.5%	  w/v	  alginate|GelMA	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To	   assess	   the	   microstructure	   of	   our	   hydrogel	   blend,	   SEM	   analysis	   was	   performed.	   Even	  
though	   it	   is	   widely	   accepted	   that	   the	   sample	   preparation	   steps	   for	   SEM	   could	   affect	   the	  
original	  hydrogel	  structure,	  SEM	  was	  solely	  used	   for	   illustrative	  purposes,	  with	   the	  aim	  of	  
investigating	  the	  difference	  between	  the	  samples	  (Chiu	  et	  al.,	  2013).	  Since	  all	  samples	  were	  
prepared	  at	  the	  same	  time	  and	  processed	  according	  to	  the	  same	  protocol,	  potential	  influence	  
on	  the	  microscopic	  structure	  is	  expected	  to	  be	  similar	  across	  all	  samples,	  rendering	  relative	  
(and	  not	  absolute),	  	  yet	  comparable	  results.	  	  
	  
Analysis	  of	  the	  microstructure	  of	  pure	  2%	  w/v	  alginate	  and	  7.5%	  w/v	  GelMA	  revealed	  
homogeneous	   and	   interconnected	   pores	   throughout	   the	   entire	   cross-­‐sectional	   area.	  
From	   the	   SEM	   images	   it	   can	   be	   seen	   that	   2%	  w/v	   alginate	   exhibits	  more	   oblong	   and	  
larger	  pores,	  compared	  to	  the	  smaller	  honeycomb-­‐like	  pores	  in	  7.5%	  w/v	  GelMA.	  These	  
results	  are	  in	  accordance	  with	  previous	  work	  from	  Yao	  et	  al.	  (2012),	  Arya	  et	  al.	  (2016),	  
and	   Athirasala	   et	   al.	   (2017),	   who	   demonstrated	   similar	   alginate	   and	   GelMA	   hydrogel	  
microstructures.	   SEM	  analysis	   of	   the	   cross-­‐sectional	   area	   of	   a	   hydrogel	   obtained	   from	  
combining	   the	   two	   polymers	   shows	   clear	   differences	   in	   architecture	   and	   porosity.	   As	  
shown	   in	   figure	  12,	   images	   obtained	   from	   this	   hybrid	   hydrogel	   show	  an	   intermediate	  
morphology	   in	   which	   clear	   distinct	   areas	   corresponding	   to	   either	   alginate	   or	   GelMA	  
accumulated	  to	  be	  the	  dominant	  component.	  As	  described	  by	  Vendamme	  et	  al.	   (2006),	  
model	  microstructures	   of	   interpenetrating	  networks	   show	   fully	   developed	   and	   evenly	  
interpenetrating	   networks.	   However,	   in	   practice,	   a	   microstructure	   in	   which	   one	  
component	   is	   dispersed	  within	   the	   other	   network,	   as	   is	   the	   case	   for	   our	   2|7.5%	  w/v	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As	   mentioned	   in	   section	   7.4,	   pilot	   LIVE/DEAD	   cell	   viability	   assays	   performed	   at	   the	  
Royal	   Adelaide	   Hospital	   revealed	   detrimental	   effects	   on	   Beta-­‐TC-­‐6	   cell	   viability	  
encapsulated	  and	  cultured	  in	  2|10%	  w/v	  alginate|GelMA.	  To	  assess	  whether	  this	  could	  
be	   related	   to	   the	   hydrogel	   microstructure,	   the	   cross-­‐sectional	   area	   of	   a	   2|10%	   w/v	  
alginate|GelMA	  hydrogel	  was	  observed	  using	  SEM	  (figure	  13).	  Images	  obtained	  from	  this	  
construct	  revealed	  a	  more	  compact	  and	  denser	  microstructure	  compared	  to	  2|7.5%	  w/v	  
alginate|GelMA	   cross-­‐sectional	   areas,	   which	   could	   have	   limited	   mass	   transfer,	   and	  
thereby	  cell	  viability,	  through	  the	  gels.	  	  To	  confirm	  this,	  further	  experiments	  will	  need	  to	  
be	   performed,	   for	   example	   glucose	   diffusion	   studies,	   as	   described	   by	   Marchioli	   et	   al.	  
(2015).	  In	  addition,	  given	  the	  nature	  of	  our	  approach	  (i.e.	  the	  use	  of	  calcium	  ions,	  which	  
are	   involved	   in	   the	   insulin	   secreting	   mechanism),	   the	   insulin	   response	   of	   the	  




Figure	  13.	  	  SEM	  images	  of	  cross-­‐sections	  of	  2|7.5%	  w/v	  alginate|GelMA	  and	  2|10%	  w/v	  alginate|GelMA.	  
	  
To	   monitor	   the	   microstructure	   of	   2|7.5%	   w/v	   alginate|GelMA	   over	   time,	   SEM	   was	  
performed	   after	   8	   and	   15	   days	   incubation	   at	   standard	   cell	   culture	   conditions.	   As	   is	  
evident	  from	  figure	  14,	  the	  average	  pore	  size	  increased	  after	  8	  days	  in	  culture,	  opening	  
up	  the	  construct.	  On	  day	  15,	  this	  became	  even	  more	  apparent.	  This	  open	  and	  bi-­‐phasic	  
porous	   structure	   supports	   the	   previous	   observations	   regarding	   cell	   distribution,	  
showing	  presence	  of	  cells	  in	  distinct	  areas,	  and	  ability	  of	  the	  hydrogel	  matrix	  to	  support	  
cell	  proliferation.	  Whereas	  these	  results	  might	  seem	  paradoxical	  when	  considering	  the	  
degradation	   experiment,	   it	   is	   noteworthy	   that	   an	   increase	   in	   porosity	   does	   not	  
necessarily	  result	  in	  a	  decrease	  in	  polymer	  dry	  weight.	  One	  possible	  explanation	  for	  this	  
observation	   could	   be	   rearrangement	   of	   the	   polymer	   chains	   over	   time,	   which	   is	   not	  
unlikely	   given	   the	   non-­‐homogenous	   and	   oppositely	   charged	   nature	   of	   this	  
alginate|GelMA	  polymer.	   To	   examine	   this	   into	  more	   detail,	   it	  would	   be	  worthwhile	   to	  
assess	   the	   swelling	   behaviour	   of	   our	  material.	   Given	   that	  wet	  mass	   is	   independent	   of	  
pore	  size,	  such	  an	  experiment	  could	  offer	  more	  insights	  into	  the	  microstructure	  of	  this	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The	  optimal	   scaffold	  pore	   size	  depends	  on	  a	  variety	  of	   factors,	   including	   the	   cell	   type.	  
For	   example,	   previous	   studies	   have	   shown	   that	   chondrocyte	   ingrowth	   requires	   pore	  
sizes	  around	  100-­‐300	  μm,	   fibroblast	   ingrowth	  requires	  pore	  sizes	  of	  approximately	  5–
15	  μm,	  and	  pore	  sizes	  of	  20–125	  μm	  are	  desirable	  for	  regeneration	  of	  adult	  mammalian	  
skin	  (El-­‐Sherbiny	  &	  Yacoub,	  2013).	  In	  addition,	  given	  that	  the	  mechanical	  properties	  are	  
linked	   to	   the	   porosity,	   it	   is	   all	   about	   finding	   the	   right	   balance	   between	   and	   sufficient	  
support.	   Keeping	   the	   final	   application	   in	   mind,	   the	   hydrogel	   architectural	   properties	  
should	  be	  appropriate	  to	  deliver,	  accommodate,	  and	  maintain	  pancreatic	  islets.	  Whereas	  
a	  microporous	  design	  would	  be	  beneficial	   in	  terms	  of	  immuno-­‐isolation,	  microporosity	  
will	   impede	   rapid	   diffusion	   of	   glucose	   and	   insulin	   (Schweicher	   et	   al.,	   2014).	   Besides,	  
given	  the	  relatively	  large	  and	  heterogeneous	  size	  of	  pancreatic	  islets,	  micropores	  could	  
be	   easily	   blocked	   by	   the	   islets,	   which	   could	   have	   inhibitory	   effects	   on	   cellular	  
penetration,	  ECM	  production,	  and	  (neo)vascularization,	  the	  latter	  requiring	  a	  pore	  size	  
of	   	  ~50μm	  (Perets	  et	  al.,	  2003).	  Solely	  considering	  the	  role	  of	  the	  hydrogel	  matrix	  as	  a	  
vehicle	   to	   deliver	   pancreatic	   islets,	   macroporosity	   would	   be	   desired.	   As	   mentioned	  
before,	  using	  SEM	  to	  characterize	  material	  morphology	  has	  its	  limitations,	  especially	  in	  
terms	   of	   providing	   quantitative	   information.	   To	   accurately	   quantify	   the	   pore	   size	  
(distribution)	   of	   our	   hydrogel	   material	   and	   to	   assess	   whether	   this	   2|7.5%	   w/v	  
alginate|GelMA	   matrix	   could	   provide	   adequate	   physical	   space	   and	   support	   for	  
pancreatic	   islets	   over	   a	   longer	   period	   of	   time,	   complementing	   experiments	   should	   be	  
performed.	  For	  example,	  it	  would	  be	  worthwhile	  to	  fluorescently	  label	  the	  material,	  and	  
assess	   its	  morphology	   by	   confocal	  microscopy.	   Another	   option	  would	   be	   imaging	   the	  





Figure	  14.	  	  SEM	  images	  of	  cross-­‐sections	  2|7.5%	  w/v	  alginate|GelMA	  immediately	  after	  encapsulation	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10.	  Looking	  back:	  general	  comments	  on	  the	  project	  and	  approach	  
	  
As	  may	  be	  evident	   from	  the	  above,	  currently	  the	  project	   is	  still	   in	   its	   infancy.	  Whereas	  
these	   pilot	   experiments	   have	   shown	   the	   potential	   of	   the	   2|7.5%	   w/v	   alginate|GelMA	  
hydrogel	   formulation	   to	   house	   relevant	   cell-­‐types,	   considerable	   work	   needs	   to	   be	  
performed.	  For	  now,	  most	  of	  the	  long-­‐term	  cytocompatibiliy	  studies	  have	  relied	  on	  the	  
MS1	  cell	  line.	  Whereas	  this	  is	  a	  –to	  the	  approach-­‐	  relevant	  cell	  source,	  this	  cell	  line	  has	  
shown	  to	  be	  very	  robust.	  Given	  the	  nature	  of	  these	  experiments,	  in	  which	  the	  cell	  source	  
plays	  a	  dominant	  role,	  it	  is	  essential	  to	  take	  into	  account	  that	  the	  beta	  cell	  (line)	  is	  more	  
sensitive	  and	  could	  respond	  differently	  to	  the	  proposed	  approach.	  In	  addition,	  whereas	  
the	   rheological	   studies	   have	   shown	   to	   be	   encouraging	   for	   future	   printing	   studies,	  
rheology	  only	  provides	  us	  with	  some	  basic	  information	  and	  actual	  validation	  should	  still	  
be	   done.	  Moreover,	   to	   date,	   no	   data	   is	   available	   on	   the	   effect	   of	   cell	   viability	   and	   cell	  
function	  once	  subjected	  to	  the	  printing	  process.	  In	  this	  case,	  it	  is	  important	  to	  compare	  
these	   results	   to	   results	   obtained	   from	   more	   standard	   cell	   culture	   environments	   (i.e.	  
endothelial	  cells	  grown	  in	  a	  collagen	  culture).	  Besides	  general	  remarks	  such	  as	  the	  need	  
for	  (biological)	  replicates	  and	  moving	  towards	  actual	  printing	  (i.e.	  avoid	  testing	  in	  bulk	  
constructs),	   it	   is	   essential	   to	   reconsider	   a	   couple	   of	   components	   when	   pursuing	   this	  
approach.	  
	  
Over	  the	  past	  years,	  various	  insulin-­‐secreting	  cell	  lines	  have	  been	  explored	  for	  diabetes	  
research,	   the	   most	   widely	   used	   ones	   being	   rat	   insulinoma	   cell	   line	   (RIN),	   hamster	  
pancreatic	   beta	   cells	   (HIT),	   transgenic	   C57BL/6	   mouse	   insulinoma	   cell	   line	   (MIN),	  
insulinoma	  cell	  line	  (INS-­‐1),	  and	  beta-­‐tumour	  cells	  βTC	  (Ulrich	  et	  al.,	  2002;	  Skelin	  et	  al.,	  
2010),	  which	  exhibit	  various	   features	   characteristics	  of	  native	  beta	   cells.	  For	  example,	  
HIT	   cells	   contain	   membrane-­‐bound	   secretory	   granules,	   which	   are	   characteristic	   for	  
normal	  hamster	  beta	  cells,	  MIN	  and	  INS-­‐1	  cells	  show	  glucose	  responsiveness	  within	  the	  
physiological	   range,	   and	   βTC	   are	   able	   to	   produce	   mature	   insulin	   and	   maintain	   the	  
features	  of	  differentiated	  beta	  cells	  for	  about	  50	  passages	  (Skelin	  et	  al.,	  2010).	  Whereas	  
these	  cell	  lines	  have	  played	  a	  central	  role	  in	  studies	  regarding	  islet	  biology,	  it	  is	  widely	  
known	  that	  cell	   lines	  do	  not	  always	  accurately	  replicate	  primary	  cell	   function	  (Kaur	  &	  
Dufour,	   2012).	   Besides,	   research	   over	   the	   past	   years	   has	   revealed	   interspecies	  
differences	   in	   islet	  architecture	  and	  composition,	  which	  has	  raised	  concerns	  regarding	  
the	  translation	  of	  non-­‐human	  based	  data	  to	  the	  human	  situation	  and	  indicates	  that	  care	  
must	   be	   taken	  when	   interpreting	   results	   (Steiner	   et	   al.,	   2010).	   Unfortunately,	   limited	  
availability	  of	  primary	  beta	  cells	  necessitates	   the	  use	  of	   these	  model	  systems.	  Keeping	  
the	  end	  goal	  in	  mind,	  it	  should	  be	  emphasized	  that	  we	  not	  are	  dealing	  with	  single	  cells,	  
but	   with	   a	   cell	   cluster,	   an	   integrated	   milieu	   of	   various	   cells	   and	   cellular	   signals,	  
surrounded	  by	  an	  array	  of	  vascular	  support	  (Penko	  et	  al.,	  2015).	  One	  relatively	  simple	  
way	   to	   increase	   complexity	   of	   the	   current	   system	   and	   enhance	   relevance	   of	   our	  
approach	   at	   this	   stage	   of	   the	   project	   is	   by	   switching	   from	   single	   cell	   studies	   to	   cell-­‐
aggregation	   studies	   (i.e.	   spheroid	   formation).	   Spheroid	   formation	   is	   generally	  
considered	   to	   be	   a	   relatively	   simple	   3D	   cell	   culture	   method	   and	   has	   shown	   to	   be	   a	  
convenient	  means	  towards	  more	  accurate	  tissue	  models	  (Achilli	  et	  al.,	  2012).	  The	  main	  
benefit	   of	   using	   spheroids	   over	   2D	   monolayer	   cultures	   is	   the	   presence	   of	   more	  
physiologically	  relevant	  diffusion	  gradients	  (e.g.	  oxygen	  and	  nutrients)	  and	  cell-­‐cell	  and	  
cell-­‐ECM	   interactions.	   As	   described	   by	   Schweicher	   et	   al.	   2014	   various	   studies	   have	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compared	  to	  single	  cells,	  illustrating	  the	  relevance	  of	  switching	  from	  single-­‐cell	  studies	  
to	  more	  complex	  cellular	  aggregates.	  	  	  
	  
	  
11.	  Future	  perspectives:	  from	  bench	  to	  bedside	  
	  
Biofabrication	  technology	  has	  shown	  to	  offer	  great	  potential	  to	  establish	  3D	  tissue-­‐like	  
constructs	  and	  thereby	  approximate	  in	  vivo-­‐like	  conditions.	  Even	  though	  biofabrication	  
technology	  and	  its	  implications	  for	  pancreatic	  tissue	  engineering	  are	  still	   in	  its	  infancy,	  
the	   technology	   is	   expected	   to	   have	   major	   impact	   on	   the	   field	   (Yue	   et	   al.,	   2016).	  
Biofabrication-­‐based	   tissue	  engineering	  approaches	  do	  not	  only	  offer	   the	  potential	   for	  
development	   of	   alternative	   transplantation	   sites,	   but	   also	   to	   actively	   promote	   islet	  
survival,	  thereby	  advancing	  the	  current	  islet	  transplantation	  procedure.	  	  
	  
Biofabrication-­‐based	  tissue	  engineering	  has	  already	  been	  an	  active	  field	  of	  research	  for	  
several	   decades.	   However,	   realizing	   clinically	   relevant	   success	   remains	   daunting,	  
especially	   when	   it	   comes	   to	   bioengineering	   of	  more	   complex	   and	   larger-­‐scale	   tissues	  
(Lovett	   et	   al.,	   2009).	   One	   of	   the	   main	   limitations	   is	   the	   lack	   of	   sufficient	   vasculature	  
(Novosel	  et	  al.,	  2011).	  Although	  this	  is	  a	  general	  encountered	  hurdle	  in	  the	  field	  of	  tissue	  
engineering,	   it	   is	   especially	   worrisome	   when	   considering	   a	   metabolically	   demanding	  
organ	   such	   as	   the	   pancreas.	  One	   other	   important,	   yet	   limiting	   aspect	   is	   related	   to	   the	  
lack	  of	  optimized	  methods	   to	  analyse	  and	  assess	   the	  more	  complex	  3D	  structures.	  For	  
decades,	  research	  was	  predominantly	  focussing	  on	  thin,	  optically	  transparent	  2D	  culture	  
modalities,	   not	   only	   in	   terms	   of	   experimental	   design,	   but	   also	   in	   terms	   of	   subsequent	  
data	  analysis.	  Whereas	  the	  increasing	  in	  vivo	  relevance	  that	  is	  offered	  by	  3D	  cell	  culture	  
modalities	  has	  its	  benefits,	  data	  interpretation	  becomes	  more	  challenging	  and	  requires	  
developments	  in	  imaging	  technologies	  and	  establishing	  standard	  protocols.	  
	  
Whereas	   the	   above-­‐mentioned	   challenges	   are	  mostly	   centred	   on	   the	   pre-­‐printing	   and	  
printing	   phase,	   it	   is	   important	   to	   anticipate	   on	   post-­‐printing	   issues.	   In	   order	   to	   bring	  
biofabrication-­‐based	  innovation	  from	  the	  bench	  to	  the	  clinic,	  it	  is	  not	  only	  necessary	  to	  
look	  into	  these	  technical	  aspects,	  but	  also	  to	  look	  beyond.	  Two	  translational	  bottlenecks	  
to	  consider	  are	   the	  ethical	   challenges	  and	   the	  need	   for	   standardization	   in	   the	   field.	  As	  
the	  biofabrication	  field	  matures,	  developments	  within	  all	  these	  converging	  technologies	  
and	  disciplines	  become	  increasingly	  important	  and	  will	  need	  to	  be	  streamlined	  in	  order	  
for	  the	  field	  to	  advance.	  	  
	  
11.1.	  The	  need	  for	  standardization	  
An	   important	  aspect	   that	  should	  be	  addressed	   is	   the	  need	   for	  standardization,	  both	   in	  
terms	   of	   biofabrication	   technology	   but	   also	   regarding	   the	   islet	   transplantation	  
procedure	  and	  their	  convergence	  (Chhaya	  et	  al.,	  2015;	  Hourd	  et	  al.,	  2015;	  Bertuzzi	  &	  De	  
Carlis,	   2016).	   Among	   the	   abundant	   literature	   describing	   biofabrication	   and	  
biofabrication	  approaches,	  a	  variety	  of	  ambiguous	  terms	  exist.	  For	  example,	  terminology	  
to	   describe	   the	   technology	   ranges	   from	   3D	   printing,	   to	   bioprinting,	   additive	  
manufacturing,	   additive	   biomanufacturing,	   and	   biofabrication,	   which	   are	   used	  
interchangeably,	   often	   without	   being	   appropriately	   defined.	   If	   the	   field	   is	   to	   move	  
forward,	  it	  is	  not	  only	  essential	  to	  establish	  standards	  in	  terms	  of	  terminology,	  but	  also	  
in	   terms	   of	   experimental	   design,	   procedures,	   and	   performance.	   In	   this	   context,	   it	   is	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biofabrication	  technology	  to	  create	  tailor-­‐made	  products	  that	  are	  integrated	  with	  living	  
cells.	  As	  described	  in	  detail	  by	  Hourd	  et	  al.	   (2015),	  points	  of	  consideration	  do	  not	  only	  
arise	   around	   testing	  and	  validation	  of	   these	   customizable	  products,	   but	   already	  at	   the	  
stage	  of	  experimental	  design.	  As	  previously	  mentioned,	  the	  ability	  to	  efficiently	  harvest	  
viable	  and	  functional	  islets	  is	  key	  in	  the	  islet	  transplantation	  approach.	  This	  is	  reflected	  
by	   the	   large	   variety	   of	   protocols	   that	   have	   been	   established	   and	   described,	   all	   having	  
their	  own	  advantages	  and	  disadvantages,	  aiming	  to	  improve	  clinical	  outcome	  (Jin	  &	  Kim,	  
2017).	   However,	   keeping	   the	   final	   goal	   in	   mind,	   which	   involves	   fabrication	   of	  
biologically	   active	   constructs	   for	   human	   use,	   a	   standardized	   method	   for	   islet	  
manufacturing,	   processing,	   and	  handling	  becomes	   increasingly	   imperative	   (Bertuzzi	  &	  
De	  Carlis,	  2016).	  Such	  a	  standardized	  procedure	  will	  not	  only	  be	  of	  benefit	   in	  terms	  of	  
improving	   knowledge	   transfer,	   enhanced	   and	   robust	   islet	   quality,	   but	   also	   ensure	  
and/or	  improve	  safety	  of	  the	  recipient.	  One	  example	  involves	  controlling	  the	  size	  of	  the	  
islets.	   Given	   that	   we	   are	   working	   with	   cell	   clusters,	   it	   is	   important	   to	   find	   robust	  
methods	   to	   obtain	   islets	   with	   equal	   and	   optimal	   dimensions.	   This	   could	   be	   done	   by	  
preselection	   of	   islets	   after	   harvesting,	   but	   also	   by	   creating	   3D	   cell	   aggregates	   (i.e.	  
microcontact	  printing,	  microwell	   systems).	   In	   addition	   to	   the	   islet	   isolation	  procedure	  
itself	   there	   is	  a	  myriad	  of	  additional	   factors	  to	  consider.	   	  Examples	  range	  from	  the	  cell	  
dose,	   cell	   source,	   materials	   for	   encapsulation,	   transplantation	   sites,	   and	   recipients,	  
which	  will	  all	  determine	  the	  outcome	  (Köllmer	  et	  al.,	  2015).	  Successful	  implementation	  
requires	   sufficient	   knowledge	   of	   the	   materials	   in	   terms	   of	   cytocompatibility,	   which	  
indeed	  influences	  performance,	  but	  also	  on	  its	  reaction	  when	  subjected	  to	  the	  printing	  
process,	  and	  to	  its	  post-­‐printing	  conditions/environment.	  One	  should	  take	  into	  account	  
that	   it	   is	   not	   only	   about	   a	   relatively	   novel	  manner	   of	  manufacturing,	   but	   also	   about	   a	  
complex	  product,	  with	   the	  potential	   to	   be	  placed	   in	   a	  dynamic	   environment.	   The	   true	  
challenge	   lies	   in	  developing	  a	   regulatory	  environment	   in	  which	  products	  pass	  a	   set	  of	  
standards	   and	   regulations,	   while	   retaining	   the	   customizable	   nature	   and	   ability	   to	  
fabricate	  patient-­‐specific	  products.	  	  
	  
11.2.	  Ethical	  considerations	  
Whereas	   the	   biofabrication	   arena	   has	   substantial	   similarities	   with	   the	   fields	   of	  
regenerative	   medicine	   and	   tissue	   engineering,	   the	   unique	   character	   of	   biofabrication	  
technology	   and	   its	   potential	   applications	   necessitates	   thorough	   biofabrication-­‐specific	  
ethical	   considerations	   (Baker	  et	  al.,	  2016;	  Otto	  et	  al.,	  2016;	  Gilbert	  et	  al.,	  2017).	  These	  
involve	  questions	   related	   to	   the	  novelty	  of	   the	   technology	   itself,	  but	  also	   regarding	   its	  
integration	  with	  biological	  products	  (e.g.	  stem	  cell	  technology).	  In	  addition,	  seen	  from	  a	  
translational-­‐application	   point	   of	   view,	   the	   great	   benefits	   that	   3D	   biofabricated	   tissue	  
products	   could	   offer	   in	   terms	   of	   personalised	   treatments	   raise	   their	   own	   ethical	  
questions.	   From	   a	   preclinical	   ‘bench-­‐side’	   perspective,	   questions	  mainly	   arise	   around	  
the	  use	  of	  animal	  and	  human	  materials.	  Several	  topics	  of	  debate	  are	  the	  choice	  and	  use	  
of	   animals,	   use	   of	   cells	   source	   d	   from	   embryonic	   and	   fetal	   tissues,	   and	   the	   privacy-­‐
related	   concerns	   associated	   with	   biobanking	   (Otto	   et	   al.,	   2016;	   Gilbert	   et	   al.,	   2017).	  
Other	   factors	   worth	   to	   consider	   include	   data	   integrity	   and	   appropriate	   study	   design,	  
which	  could	  prevent	  premature	  transition	  from	  the	  bench	  to	  the	  bedside	  stage	  (Baker	  et	  
al.,	   2016).	   This	   bedside	   stage,	   which	   involves	   clinical	   trials,	   predominantly	   addresses	  
questions	  related	  to	  the	  participants;	  selection	  of	  participants,	  and	  most	  importantly,	  the	  
risks	  for	  the	  participant,	  which	  should	  be	  appropriate	  compared	  to	  the	  potential	  benefits	  
on	  the	  larger	  scale.	  Lastly,	  there	  are	  society-­‐related	  ethical	  considerations,	  which	  include	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perception	   is	   highly	   influenced	   by	   the	   public	  media.	   To	  make	   scientific	   developments	  
more	   accessible	   to	   the	   general	   audience,	   complex	   findings	   are	   usually	   presented	  with	  
excessive	   enthusiasm,	   giving	   weight	   to	   particular	   aspects	   of	   the	   topic.	   Given	   the	  
multidisciplinary	   character	   and	   unknown	   risks	   of	   biofabrication	   technology,	  
biofabricated	  products,	  and	  their	  possible	  applications,	  it	  may	  be	  difficult	  to	  look	  beyond	  
the	   hype.	   However,	   it	   is	   crucial	   to	   realize	   that	   the	   manner	   of	   reporting	   affects	   the	  
public’s	   view	   on	   science.	   Overselling	   could	   easily	   lead	   to	   false	   expectations,	  
disappointment,	  and	  eventually	  distrust	   in	  researchers	  and	  the	  technology.	  Sufficiently	  
informing	   the	  public	   is	  essential	   for	  appropriate	  general	  understanding	  of	   science	  and	  
could	  help	  when	  leading	  discussions	  on	  related	  topics	  (e.g.	  the	  role	  of	  biofabrication	  on	  




In	  this	  work,	  alginate|GelMA	  was	  evaluated	  as	  a	  potential	  vehicle	   for	  extrahepatic	   islet	  
transplantation.	   The	   hydrogel	   ink	   was	   assessed	   in	   terms	   of	   stability,	   rheological	  
properties,	  the	  ability	  to	  house	  relevant	  cell	  types	  (i.e.),	  and	  the	  microstructure.	  Whereas	  
substantial	  work	  remains	  to	  be	  performed,	  these	  initial	  experiments	  have	  demonstrated	  
the	  ability	  of	  this	  hybrid	  hydrogel	  material	  to	  house	  and	  maintain	  relevant	  cell	  types	  for	  
an	   adequate	   period	   of	   time,	   which	   together	   demonstrate	   its	   potential	   as	   a	   promising	  
base-­‐material	   for	   biofabrication-­‐based	   tissue	   engineering	   of	   bioartifical	   pancreatic	  
constructs.	  Keeping	  the	  final	  application	  in	  mind,	  one	  should	  realize	  that	  biofabrication	  
encompasses	  a	  variety	  of	  disciplines,	  and	  needs	  the	  constructive	  collaboration	  between	  
engineers,	  scientists,	  and	  clinicians.	  For	  the	  field	  to	  progress	  beyond	  the	  bench-­‐side,	  it	  is	  
essential	  to	  think	  ahead	  along	  the	  line	  of	  research.	  Successful	  implementation	  of	  a	  novel	  
biotechnology	   such	   as	   biofabrication	   requires	   scientists	   to	   look	   beyond	   experimental	  
design,	   and	   consider	   the	   interplay	   between	   their	   research	   and	   associated	   (potential)	  




I	  wish	  to	  express	  my	  sincere	  gratitude	  to	  my	  co-­‐supervisors	  Dr.	  Zhilian	  Yue	  and	  Dr.	  Xiao	  
Liu	  for	  their	  assistance	  during	  the	  entire	  project.	  I	  specifically	  thank	  them	  for	  allowing	  
me	  to	  work	   independently,	  while	  making	  sure	  to	  guide	  me	  in	  the	  right	  direction	  when	  
needed.	  Your	  endless	  support,	  trust,	  and	  positivity	  are	  highly	  appreciated.	  I	  would	  like	  to	  
extend	  my	  gratitude	  to	  my	  clinical	  mentor,	  Prof.	  Dr.	  Patrick	  T.	  Coates	  for	  offering	  me	  the	  
opportunity	   to	   visit	   his	   lab,	   explore	   the	  other	   side	  of	   the	  project,	   and	  his	   constructive	  
comments	   throughout	   the	   year.	   I	   thank	   my	   fellow	   students,	   MSc.	   Yu	   Hu,	   BSc.	   Kyung	  
Kang,	  and	  BSc.	   Juewan	  Kim.	   It	  was	  great	   to	  explore	   the	  project	   together,	   to	   learn	  with	  
and	  from	  you,	  and	  to	  share	  ideas.	  Lastly,	  I	  would	  like	  to	  thank	  Prof.	  Dr.	  Gordon	  Wallace	  
and	   Prof.	   Dr.	   Jos	   Malda	   for	   their	   guidance	   during	   the	   past	   year	   and	   giving	   me	   the	  













36	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
14.	  References	  
	  
Achilli,	  T.	  M.,	  Meyer,	   J.,	  &	  Morgan,	   J.	  R.	  (2012).	  Advances	   in	  the	  formation,	  use	  and	  understanding	  of	  
multi-­‐cellular	  spheroids.	  Expert	  opinion	  on	  biological	  therapy,	  12(10),	  1347-­‐1360.	  
	  
Ahadian,	  S.,	  Sadeghian,	  R.	  B.,	  Salehi,	  S.,	  Ostrovidov,	  S.,	  Bae,	  H.,	  Ramalingam,	  M.,	  &	  Khademhosseini,	  A.	  
(2015).	   Bioconjugated	   hydrogels	   for	   tissue	   engineering	   and	   regenerative	   medicine.	  Bioconjugate	  
chemistry,	  26(10),	  1984-­‐2001.	  
	  
Aparnathi,	  M.	  K.,	  &	  Patel,	   J.	  S.	  (2016).	  Biodegradable	  Gelatin	  Methacrylate	  Gel	  as	  a	  Potential	  Scaffold	  
for	  Bone	  Tissue	  Engineering	  of	  Canine	  Adipose-­‐Derived	  Stem	  Cells.	  Journal	  of	  Stem	  Cells,	  11(3),	  111.	  
	  
Aronoff,	   S.	   L.,	   Berkowitz,	   K.,	   Shreiner,	   B.,	   &	   Want,	   L.	   (2004).	   Glucose	   metabolism	   and	   regulation:	  
beyond	  insulin	  and	  glucagon.	  Diabetes	  Spectrum,	  17(3),	  183-­‐190.	  
	  
Arya,	   A.	   D.,	   Hallur,	   P.	  M.,	   Karkisaval,	   A.	   G.,	   Gudipati,	   A.,	   Rajendiran,	   S.,	   Dhavale,	   V.,	   ...	   &	   Chaubey,	   A.	  
(2016).	   Gelatin	   Methacrylate	   Hydrogels	   as	   Biomimetic	   Three-­‐Dimensional	   Matrixes	   for	   Modeling	  
Breast	  Cancer	  Invasion	  and	  Chemoresponse	  in	  Vitro.	  ACS	  applied	  materials	  &	  interfaces,	  8(34),	  22005-­‐
22017.	  
	  
Assmann,	   A.,	   Hinault,	   C.,	   &	   Kulkarni,	   R.	   N.	   (2009).	   Growth	   factor	   control	   of	   pancreatic	   islet	  
regeneration	  and	  function.	  Pediatric	  diabetes,	  10(1),	  14-­‐32.	  
	  
Augst,	  A.	  D.,	  Kong,	  H.	   J.,	  &	  Mooney,	  D.	   J.	   (2006).	  Alginate	  hydrogels	   as	  biomaterials.	  Macromolecular	  
bioscience,	  6(8),	  623-­‐633.	  
	  
Athirasala,	  A.,	  Lins,	  F.,	  Tahayeri,	  A.,	  Hinds,	  M.,	  Smith,	  A.	   J.,	  Sedgley,	  C.,	   ...	  &	  Bertassoni,	  L.	  E.	  (2017).	  A	  
Novel	  Strategy	  to	  Engineer	  Pre-­‐Vascularized	  Full-­‐Length	  Dental	  Pulp-­‐like	  Tissue	  Constructs.	  Scientific	  
Reports,	  7.	  
	  
Baker,	   H.	   B.,	   McQuilling,	   J.	   P.,	   &	   King,	   N.	   M.	   (2016).	   Ethical	   considerations	   in	   tissue	   engineering	  
research:	  case	  studies	  in	  translation.	  Methods,	  99,	  135-­‐144.	  
	  
Banerjee,	  A.,	  Arha,	  M.,	  Choudhary,	  S.,	  Ashton,	  R.	  S.,	  Bhatia,	  S.	  R.,	  Schaffer,	  D.	  V.,	  &	  Kane,	  R.	  S.	  (2009).	  The	  
influence	   of	   hydrogel	  modulus	   on	   the	  proliferation	   and	  differentiation	   of	   encapsulated	  neural	   stem	  
cells.	  Biomaterials,	  30(27),	  4695-­‐4699.	  
	  
Bellin,	  M.	  D.,	  Barton,	  F.	  B.,	  Heitman,	  A.,	  Harmon,	  J.	  V.,	  Kandaswamy,	  R.,	  Balamurugan,	  A.	  N.,	  ...	  &	  Hering,	  
B.	  J.	  (2012).	  Potent	  Induction	  Immunotherapy	  Promotes	  Long-­‐Term	  Insulin	  Independence	  After	  Islet	  
Transplantation	  in	  Type	  1	  Diabetes.	  American	  Journal	  of	  Transplantation,	  12(6),	  1576-­‐1583.	  
	  
Bennet,	  W.,	  Groth,	  C.	  G.,	  Larsson,	  R.,	  Nilsson,	  B.,	  &	  Korsgren,	  O.	  (2000).	  Isolated	  human	  islets	  trigger	  an	  
instant	  blood	  mediated	  inflammatory	  reaction:	   implications	  for	   intraportal	   islet	  transplantation	  as	  a	  
treatment	  for	  patients	  with	  type	  1	  diabetes.	  Upsala	  journal	  of	  medical	  sciences,	  105(2),	  125-­‐133.	  
	  
Berthiaume,	  F.,	  Maguire,	  T.	  J.,	  &	  Yarmush,	  M.	  L.	  (2011).	  Tissue	  engineering	  and	  regenerative	  medicine:	  
history,	  progress,	  and	  challenges.	  Annual	  review	  of	  chemical	  and	  biomolecular	  engineering,	  2,	  403-­‐430.	  
	  
Bertuzzi,	  F.,	  &	  De	  Carlis,	  L.	  G.	  (2016).	  Human	  Pancreatic	  Islet	  Production:	  From	  Research	  Protocols	  to	  
Standardized	  Multicenter	  Manufacturing.	  Diabetes,	  65(11),	  3243-­‐3245.	  
	  
Boontheekul,	   T.,	   Kong,	   H.	   J.,	   &	   Mooney,	   D.	   J.	   (2005).	   Controlling	   alginate	   gel	   degradation	   utilizing	  
partial	  oxidation	  and	  bimodal	  molecular	  weight	  distribution.	  Biomaterials,	  26(15),	  2455-­‐2465.	  
	  
Borg,	   D.	   J.,	   &	   Bonifacio,	   E.	   (2011).	   The	   use	   of	   biomaterials	   in	   islet	   transplantation.	  Current	  diabetes	  
reports,	  11(5),	  434-­‐444.	  
	  
Bottino,	   R.,	   &	   Trucco,	   M.	   (2015).	   Clinical	   implementation	   of	   islet	   transplantation:	   A	   current	  






37	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
	  
Bottino,	   R.,	   &	   Trucco,	   M.	   (2015).	   Use	   of	   genetically-­‐engineered	   pig	   donors	   in	   islet	  
transplantation.	  World	  journal	  of	  transplantation,	  5(4),	  243.	  
	  
Brissova,	   M.,	   &	   Powers,	   A.	   C.	   (2008).	   Revascularization	   of	   Transplanted	   Islets	   Can	   It	   Be	  
Improved?.	  Diabetes,	  57(9),	  2269-­‐2271.	  
	  
Bruns,	  H.,	  Schultze,	  D.,	  &	  Schemmer,	  P.	  (2013).	  Alternatives	  to	  islet	  transplantation:	  future	  cell	  sources	  
of	  beta-­‐like	  cells.	  Clinical	  transplantation,	  27(s25),	  30-­‐33.	  
	  
Caicedo,	  A.	  (2013,	  January).	  Paracrine	  and	  autocrine	  interactions	  in	  the	  human	  islet:	  more	  than	  meets	  
the	  eye.	  In	  Seminars	  in	  cell	  &	  developmental	  biology(Vol.	  24,	  No.	  1,	  pp.	  11-­‐21).	  Academic	  Press.	  
	  
Cantarelli,	  E.,	  Citro,	  A.,	  &	  Piemonti,	  L.	  (2017).	  Pancreatic	  Islet	  Transplantation	  Technologies:	  State	  of	  
the	  Art	  of	  Micro-­‐and	  Macro-­‐Encapsulation.	  Current	  Transplantation	  Reports,	  1-­‐15.	  
	  
Cantarelli,	   E.,	   &	   Piemonti,	   L.	   (2011).	   Alternative	   transplantation	   sites	   for	   pancreatic	   islet	  
grafts.	  Current	  diabetes	  reports,	  11(5),	  364-­‐374.	  
	  
Carlsson,	   P.	   O.,	   Palm,	   F.,	   Andersson,	   A.,	   &	   Liss,	   P.	   (2001).	   Markedly	   decreased	   oxygen	   tension	   in	  
transplanted	  rat	  pancreatic	  islets	  irrespective	  of	  the	  implantation	  site.	  Diabetes,	  50(3),	  489-­‐495.	  
	  
Carrow,	  J.	  K.,	  Kerativitayanan,	  P.,	  Jaiswal,	  M.	  K.,	  Lokhande,	  G.,	  &	  Gaharwar,	  A.	  K.	  (2015).	  Polymers	  for	  
Bioprinting.	  
	  
Carter,	  S.	  S.	  D.,	  Costa,	  P.	  F.,	  Vaquette,	  C.,	   Ivanovski,	  S.,	  Hutmacher,	  D.	  W.,	  &	  Malda,	   J.	   (2016).	  Additive	  
biomanufacturing:	   an	   advanced	   approach	   for	   periodontal	   tissue	   regeneration.	  Annals	   of	   Biomedical	  
Engineering,	  1-­‐11.	  
	  
Carter,	  J.	  D.,	  Dula,	  S.	  B.,	  Corbin,	  K.	  L.,	  Wu,	  R.,	  &	  Nunemaker,	  C.	  S.	  (2009).	  A	  practical	  guide	  to	  rodent	  islet	  
isolation	  and	  assessment.	  Biological	  procedures	  online,	  11(1),	  3.	  
	  
Cavo,	   M.,	   Fato,	   M.,	   Peñuela,	   L.,	   Beltrame,	   F.,	   Raiteri,	   R.,	   &	   Scaglione,	   S.	   (2016).	   Microenvironment	  
complexity	   and	  matrix	   stiffness	   regulate	  breast	   cancer	   cell	   activity	   in	   a	  3D	   in	   vitro	  model.	  Scientific	  
reports,	  6,	  35367.	  
	  
Cerf,	  M.	  E.	  (2013).	  Beta	  cell	  dysfunction	  and	  insulin	  resistance.	  Frontiers	  in	  endocrinology,	  4.	  
	  
Chhaya,	  M.	  P.,	  Poh,	  P.	  S.,	  Balmayor,	  E.	  R.,	  van	  Griensven,	  M.,	  Schantz,	  J.	  T.,	  &	  Hutmacher,	  D.	  W.	  (2015).	  
Additive	  manufacturing	  in	  biomedical	  sciences	  and	  the	  need	  for	  definitions	  and	  norms.	  Expert	  review	  
of	  medical	  devices,	  12(5),	  537-­‐543.	  
	  
Chiu,	  Y.	  C.,	  Cheng,	  M.	  H.,	  Engel,	  H.,	  Kao,	  S.	  W.,	  Larson,	  J.	  C.,	  Gupta,	  S.,	  &	  Brey,	  E.	  M.	  (2011).	  The	  role	  of	  
pore	   size	   on	   vascularization	   and	   tissue	   remodeling	   in	   PEG	   hydrogels.	  Biomaterials,	  32(26),	   6045-­‐
6051.	  
	  
Chiu,	   Y.	   C.,	   Kocagöz,	   S.,	   Larson,	   J.	   C.,	   &	   Brey,	   E.	   M.	   (2013).	   Evaluation	   of	   physical	   and	   mechanical	  
properties	   of	   porous	   poly	   (ethylene	   glycol)-­‐co-­‐(l-­‐lactic	   acid)	   hydrogels	   during	   degradation.	  PLoS	  
One,	  8(4),	  e60728.	  
	  
Chung,	   J.	  H.,	  Naficy,	   S.,	   Yue,	   Z.,	  Kapsa,	  R.,	  Quigley,	  A.,	  Moulton,	   S.	  E.,	  &	  Wallace,	  G.	  G.	   (2013).	  Bio-­‐ink	  
properties	  and	  printability	  for	  extrusion	  printing	  living	  cells.	  Biomaterials	  Science,	  1(7),	  763-­‐773.	  
	  
Cohen,	   D.	   L.,	   Lo,	   W.,	   Tsavaris,	   A.,	   Peng,	   D.,	   Lipson,	   H.,	   &	   Bonassar,	   L.	   J.	   (2010).	   Increased	   mixing	  
improves	   hydrogel	   homogeneity	   and	   quality	   of	   three-­‐dimensional	   printed	   constructs.	  Tissue	  
engineering	  Part	  C:	  methods,	  17(2),	  239-­‐248.	  
	  
Cornock,	   R.,	   Beirne,	   S.,	   Thompson,	   B.,	   &	   Wallace,	   G.	   G.	   (2014).	   Coaxial	   additive	   manufacture	   of	  






38	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
	  
Costantini,	   M.,	   Idaszek,	   J.,	   Szöke,	   K.,	   Jaroszewicz,	   J.,	   Dentini,	   M.,	   Barbetta,	   A.,	   ...	   &	   Święszkowski,	  W.	  
(2016).	   3D	   bioprinting	   of	   BM-­‐MSCs-­‐loaded	   ECM	   biomimetic	   hydrogels	   for	   in	   vitro	   neocartilage	  
formation.	  Biofabrication,	  8(3),	  035002.	  
	  
Daoud,	  J.	  T.,	  Petropavlovskaia,	  M.	  S.,	  Patapas,	  J.	  M.,	  Degrandpré,	  C.	  E.,	  DiRaddo,	  R.	  W.,	  Rosenberg,	  L.,	  &	  
Tabrizian,	   M.	   (2011).	   Long-­‐term	   in	   vitro	   human	   pancreatic	   islet	   culture	   using	   three-­‐dimensional	  
microfabricated	  scaffolds.	  Biomaterials,	  32(6),	  1536-­‐1542.	  
	  
Desai,	   T.,	   &	   Shea,	   L.	   D.	   (2016).	   Advances	   in	   islet	   encapsulation	   technologies.	  Nature	   Reviews	   Drug	  
Discovery.	  
	  
Dubbin,	   K.,	   Hori,	   Y.,	   Lewis,	   K.	   K.,	   &	   Heilshorn,	   S.	   C.	   (2016).	   Dual-­‐Stage	   Crosslinking	   of	   a	   Gel-­‐Phase	  
Bioink	   Improves	   Cell	   Viability	   and	   Homogeneity	   for	   3D	   Bioprinting.	  Advanced	   healthcare	  
materials,	  5(19),	  2488-­‐2492.	  
	  
El-­‐Sherbiny,	   I.	   M.,	   &	   Yacoub,	  M.	   H.	   (2013).	   Hydrogel	   scaffolds	   for	   tissue	   engineering:	   Progress	   and	  
challenges.	  Global	  Cardiology	  Science	  and	  Practice,	  38.	  
	  
Fedorovich,	  N.	  E.,	  Schuurman,	  W.,	  Wijnberg,	  H.	  M.,	  Prins,	  H.	  J.,	  van	  Weeren,	  P.	  R.,	  Malda,	  J.,	   ...	  &	  Dhert,	  
W.	  J.	  (2011).	  Biofabrication	  of	  osteochondral	  tissue	  equivalents	  by	  printing	  topologically	  defined,	  cell-­‐
laden	  hydrogel	  scaffolds.	  Tissue	  Engineering	  Part	  C:	  Methods,	  18(1),	  33-­‐44.	  
	  
Ferris,	   C.	   J.,	   Gilmore,	   K.	   J.,	   Beirne,	   S.,	  McCallum,	   D.,	   &	  Wallace,	   G.	   G.	   (2013).	   Bio-­‐ink	   for	   on-­‐demand	  
printing	  of	  living	  cells.	  Biomaterials	  Science,	  1(2),	  224-­‐230.	  
	  
Gao,	  Q.,	  He,	  Y.,	   Fu,	   J.	   Z.,	   Liu,	  A.,	  &	  Ma,	  L.	   (2015).	  Coaxial	  nozzle-­‐assisted	  3D	  bioprinting	  with	  built-­‐in	  
microchannels	  for	  nutrients	  delivery.	  Biomaterials,	  61,	  203-­‐215.	  
	  
Gilbert,	   F.,	   O’Connell,	   C.	   D.,	   Mladenovska,	   T.,	   &	   Dodds,	   S.	   (2017).	   Print	   Me	   an	   Organ?	   Ethical	   and	  
Regulatory	  Issues	  Emerging	  from	  3D	  Bioprinting	  in	  Medicine.	  Science	  and	  Engineering	  Ethics,	  1-­‐19.	  
	  
Groll,	   J.,	   Boland,	   T.,	   Blunk,	   T.,	   Burdick,	   J.	   A.,	   Cho,	   D.	   W.,	   Dalton,	   P.	   D.,	   ...	   &	   Moroni,	   L.	   (2016).	  
Biofabrication:	  reappraising	  the	  definition	  of	  an	  evolving	  field.Biofabrication,	  8(1),	  013001.	  
	  
Harlan,	   D.	   M.,	   Kenyon,	   N.	   S.,	   Korsgren,	   O.,	   Roep,	   B.	   O.,	   &	   Immunology	   of	   Diabetes	   Society.	   (2009).	  
Current	  advances	  and	  travails	  in	  islet	  transplantation.	  Diabetes,	  58(10),	  2175-­‐2184.	  
	  
Hlavaty,	   K.	   A.,	   Gibly,	   R.	   F.,	   Zhang,	   X.,	   Rives,	   C.	   B.,	   Graham,	   J.	   G.,	   Lowe,	  W.	   L.,	   ...	   &	   Shea,	   L.	   D.	   (2014).	  
Enhancing	   human	   islet	   transplantation	   by	   localized	   release	   of	   trophic	   factors	   from	   PLG	   scaffolds.	  
American	  Journal	  of	  Transplantation,	  14(7),	  1523-­‐1532.	  
	  
Hölzl,	   K.,	   Lin,	   S.,	   Tytgat,	   L.,	   Van	   Vlierberghe,	   S.,	   Gu,	   L.,	   &	   Ovsianikov,	   A.	   (2016).	   Bioink	   properties	  
before,	  during	  and	  after	  3D	  bioprinting.	  Biofabrication,	  8(3),	  032002.	  
	  
Home,	  P.	  D.	  (2015).	  Plasma	  insulin	  profiles	  after	  subcutaneous	  injection:	  how	  close	  can	  we	  get	  to	  
physiology	  in	  people	  with	  diabetes?.	  Diabetes,	  Obesity	  and	  Metabolism,	  17(11),	  1011-­‐1020.	  
	  
Hourd,	   P.,	   Medcalf,	   N.,	   Segal,	   J.,	   &	   Williams,	   D.	   J.	   (2015).	   A	   3D	   bioprinting	   exemplar	   of	   the	  
consequences	  of	  the	  regulatory	  requirements	  on	  customized	  processes.	  Regenerative	  medicine,	  10(7),	  
863-­‐883.	  
	  
Jia,	  W.,	  Gungor-­‐Ozkerim,	  P.	   S.,	   Zhang,	  Y.	   S.,	   Yue,	  K.,	   Zhu,	  K.,	   Liu,	  W.,	   ...	  &	  Khademhosseini,	  A.	   (2016).	  
Direct	  3D	  bioprinting	  of	  perfusable	  vascular	  constructs	  using	  a	  blend	  bioink.	  Biomaterials,	  106,	  58-­‐68.	  
	  
Jiang,	  L.,	  &	  Granick,	  S.	  (2016).	  Real-­‐space,	  in	  situ	  maps	  of	  hydrogel	  pores.	  ACS	  nano,	  11(1),	  204-­‐212.	  
	  
Jin,	   S.	  M.,	   &	  Kim,	   K.	  W.	   (2017).	   Is	   islet	   transplantation	   a	   realistic	   approach	   to	   curing	   diabetes?.	  The	  






39	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
	  
Kadri,	  R.,	  Messaoud,	  G.	  B.,	  Tamayol,	  A.,	  Aliakbarian,	  B.,	  Zhang,	  H.	  Y.,	  Hasan,	  M.,	   ...	  &	  Arab-­‐Tehrany,	  E.	  
(2016).	   Preparation	   and	   characterization	   of	   nanofunctionalized	   alginate/methacrylated	   gelatin	  
hybrid	  hydrogels.	  RSC	  Advances,	  6(33),	  27879-­‐27884.	  
	  
Kaur,	  G.,	  &	  Dufour,	  J.	  M.	  (2012).	  Cell	  lines:	  Valuable	  tools	  or	  useless	  artifacts.	  
	  
Klotz,	   B.	   J.,	   Gawlitta,	   D.,	   Rosenberg,	   A.	   J.,	   Malda,	   J.,	   &	   Melchels,	   F.	   P.	   (2016).	   Gelatin-­‐Methacryloyl	  
Hydrogels:	  Towards	  Biofabrication-­‐Based	  Tissue	  Repair.Trends	  in	  biotechnology,	  34(5),	  394-­‐407.	  
	  
Kolesky,	   D.	   B.,	   Truby,	   R.	   L.,	   Gladman,	   A.,	   Busbee,	   T.	   A.,	   Homan,	   K.	   A.,	   &	   Lewis,	   J.	   A.	   (2014).	   3D	  
bioprinting	   of	   vascularized,	   heterogeneous	   cell-­‐laden	   tissue	   constructs.	  Advanced	  materials,	  26(19),	  
3124-­‐3130.	  
	  
Köllmer,	  M.,	  Appel,	  A.	  A.,	  Somo,	  S.	  I.,	  &	  Brey,	  E.	  M.	  (2015).	  Long-­‐term	  function	  of	  alginate-­‐encapsulated	  
islets.	  Tissue	  Engineering	  Part	  B:	  Reviews,	  22(1),	  34-­‐46.	  
	  
Kong,	  H.	  J.,	  Smith,	  M.	  K.,	  &	  Mooney,	  D.	  J.	  (2003).	  Designing	  alginate	  hydrogels	  to	  maintain	  viability	  of	  
immobilized	  cells.	  Biomaterials,	  24(22),	  4023-­‐4029.	  
	  
Laschke,	  M.	  W.,	  &	  Menger,	  M.	  D.	   (2016).	   Prevascularization	   in	   tissue	   engineering:	   Current	   concepts	  
and	  future	  directions.	  Biotechnology	  advances,	  34(2),	  112-­‐121.	  
	  
Lee,	   K.	   Y.,	   &	   Mooney,	   D.	   J.	   (2012).	   Alginate:	   properties	   and	   biomedical	   applications.	  Progress	   in	  
polymer	  science,	  37(1),	  106-­‐126.	  
	  
Lee,	  K.,	  Silva,	  E.	  A.,	  &	  Mooney,	  D.	   J.	   (2011).	  Growth	  factor	  delivery-­‐based	  tissue	  engineering:	  general	  
approaches	   and	   a	   review	  of	   recent	  developments.	   Journal	  of	   the	  Royal	  Society	   Interface,	  8(55),	   153-­‐
170.	  
	  
Loessner,	   D.,	  Meinert,	   C.,	   Kaemmerer,	   E.,	  Martine,	   L.	   C.,	   Yue,	   K.,	   Levett,	   P.	   A.,	   ...	   &	  Hutmacher,	   D.	  W.	  
(2016).	  Functionalization,	  preparation	  and	  use	  of	  cell-­‐laden	  gelatin	  methacryloyl-­‐based	  hydrogels	  as	  
modular	  tissue	  culture	  platforms.	  Nature	  protocols,	  11(4),	  727-­‐746.	  
	  
Lovett,	   M.,	   Lee,	   K.,	   Edwards,	   A.,	   &	   Kaplan,	   D.	   L.	   (2009).	   Vascularization	   strategies	   for	   tissue	  
engineering.	  Tissue	  Engineering	  Part	  B:	  Reviews,	  15(3),	  353-­‐370.	  
	  
Malda,	  J.,	  Visser,	  J.,	  Melchels,	  F.	  P.,	  Jüngst,	  T.,	  Hennink,	  W.	  E.,	  Dhert,	  W.	  J.,	  ...	  &	  Hutmacher,	  D.	  W.	  (2013).	  
25th	  anniversary	  article:	  engineering	  hydrogels	  for	  biofabrication.	  Advanced	  materials,	  25(36),	  5011-­‐
5028.	  
	  
Marchioli,	  G.,	  Luca,	  A.	  D.,	  de	  Koning,	  E.,	  Engelse,	  M.,	  Van	  Blitterswijk,	  C.	  A.,	  Karperien,	  M.,	  ...	  &	  Moroni,	  L.	  
(2016).	   Hybrid	   Polycaprolactone/Alginate	   Scaffolds	   Functionalized	  with	   VEGF	   to	   Promote	   de	  Novo	  
Vessel	  Formation	  for	  the	  Transplantation	  of	  Islets	  of	  Langerhans.	  Advanced	  healthcare	  materials.	  
	  
Marchioli,	  G.,	  Van	  Gurp,	  L.,	  Van	  Krieken,	  P.	  P.,	  Stamatialis,	  D.,	  Engelse,	  M.,	  Van	  Blitterswijk,	  C.	  A.,	   ...	  &	  
Van	  Apeldoorn,	  A.	  A.	  (2015).	  Fabrication	  of	  three-­‐dimensional	  bioplotted	  hydrogel	  scaffolds	  for	  islets	  
of	  Langerhans	  transplantation.	  Biofabrication,	  7(2),	  025009.	  
	  
Marklein,	  R.	  A.,	  &	  Burdick,	  J.	  A.	  (2010).	  Spatially	  controlled	  hydrogel	  mechanics	  to	  modulate	  stem	  cell	  
interactions.	  Soft	  Matter,	  6(1),	  136-­‐143.	  
	  
Mason,	   B.	   N.,	   Califano,	   J.	   P.,	   &	   Reinhart-­‐King,	   C.	   A.	   (2012).	   Matrix	   stiffness:	   A	   regulator	   of	   cellular	  
behavior	   and	   tissue	   formation.	   In	  Engineering	   Biomaterials	   for	   Regenerative	   Medicine	  (pp.	   19-­‐37).	  
Springer	  New	  York.	  
	  
McCall,	  M.,	  &	  Shapiro,	  A.	  J.	  (2012).	  Update	  on	  islet	  transplantation.	  Cold	  Spring	  Harbor	  perspectives	  in	  







40	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
McCall,	  M.	  D.,	  Toso,	  C.,	  Baetge,	  E.	  E.,	  &	  Shapiro,	  A.	  J.	  (2009).	  Are	  stem	  cells	  a	  cure	  for	  diabetes?.	  Clinical	  
Science,	  118(2),	  87-­‐97.	  
	  
Melchels,	  F.	  P.,	  Domingos,	  M.	  A.,	  Klein,	  T.	  J.,	  Malda,	  J.,	  Bartolo,	  P.	  J.,	  &	  Hutmacher,	  D.	  W.	  (2012).	  Additive	  
manufacturing	  of	  tissues	  and	  organs.	  Progress	  in	  Polymer	  Science,	  37(8),	  1079-­‐1104.	  
	  
Menger,	  M.	  D.,	  Yamauchi,	   J.	   I.,	  &	  Vollmar,	  B.	   (2001).	  Revascularization	  and	  microcirculation	  of	   freely	  
grafted	  islets	  of	  Langerhans.	  World	  journal	  of	  surgery,	  25(4),	  509-­‐515.	  
	  
Moore,	  S.	  J.,	  Gala-­‐Lopez,	  B.	  L.,	  Pepper,	  A.	  R.,	  Pawlick,	  R.	  L.,	  &	  Shapiro,	  A.	  J.	  (2015).	  Bioengineered	  stem	  
cells	  as	  an	  alternative	  for	  islet	  cell	  transplantation.	  World	  journal	  of	  transplantation,	  5(1),	  1.	  
	  
Morini,	   S.,	   Brown,	   M.	   L.,	   Cicalese,	   L.,	   Elias,	   G.,	   Carotti,	   S.,	   Gaudio,	   E.,	   &	   Rastellini,	   C.	   (2007).	  
Revascularization	   and	   remodelling	   of	   pancreatic	   islets	   grafted	   under	   the	   kidney	   capsule.	  Journal	   of	  
anatomy,	  210(5),	  565-­‐577.	  
	  
Mouser,	   V.	   H.,	   Melchels,	   F.	   P.,	   Visser,	   J.,	   Dhert,	   W.	   J.,	   Gawlitta,	   D.,	   &	   Malda,	   J.	   (2016).	   Yield	   stress	  
determines	   bioprintability	   of	   hydrogels	   based	   on	   gelatin-­‐methacryloyl	   and	   gellan	   gum	   for	   cartilage	  
bioprinting.	  Biofabrication,	  8(3),	  035003.	  
	  
Murphy,	   S.	   V.,	  &	  Atala,	   A.	   (2014).	   3D	  bioprinting	   of	   tissues	   and	   organs.	  Nature	  biotechnology,	  32(8),	  
773-­‐785.	  
	  
Murphy,	   S.	   V.,	   Skardal,	   A.,	   &	   Atala,	   A.	   (2013).	   Evaluation	   of	   hydrogels	   for	   bio-­‐printing	  
applications.	  Journal	  of	  Biomedical	  Materials	  Research	  Part	  A,101(1),	  272-­‐284	  
	  
Nathan,	   D.	   M.	   (1993).	   Long-­‐term	   complications	   of	   diabetes	   mellitus.	  New	   England	   Journal	   of	  
Medicine,	  328(23),	  1676-­‐1685.	  
	  
Novosel,	   E.	   C.,	   Kleinhans,	   C.,	   &	   Kluger,	   P.	   J.	   (2011).	   Vascularization	   is	   the	   key	   challenge	   in	   tissue	  
engineering.	  Advanced	  drug	  delivery	  reviews,	  63(4),	  300-­‐311.	  
	  
O'brien,	  F.	  J.	  (2011).	  Biomaterials	  &	  scaffolds	  for	  tissue	  engineering.	  Materials	  today,	  14(3),	  88-­‐95.	  
	  
O'Connell,	  C,	  D.,	  Di	  Bella,	  C.,	  Thompson,	  F.,	  Augustine,	  C.,	  Beirne,	  S.,	  Cornock,	  R.,	  ...	  &	  Bourke,	  J.	  (2016).	  
Development	  of	  the	  Biopen:	  a	  handheld	  device	  for	  surgical	  printing	  of	  adipose	  stem	  cells	  at	  a	  chondral	  
wound	  site.	  Biofabrication,	  8(1),	  015019.	  
	  
Otto,	   I.	   A.,	   Breugem,	   C.	   C.,	   Malda,	   J.,	   &	   Bredenoord,	   A.	   L.	   (2016).	   Ethical	   considerations	   in	   the	  
translation	   of	   regenerative	   biofabrication	   technologies	   into	   clinic	   and	   society.	  Biofabrication,	  8(4),	  
042001.	  
	  
Panouille,	  M.,	  &	   Larreta-­‐Garde,	   V.	   (2009).	   Gelation	  behaviour	   of	   gelatin	   and	   alginate	  mixtures.	  Food	  
hydrocolloids,	  23(4),	  1074-­‐1080.	  
	  
Pawar,	   S.	   N.,	   &	   Edgar,	   K.	   J.	   (2012).	   Alginate	   derivatization:	   a	   review	   of	   chemistry,	   properties	   and	  
applications.	  Biomaterials,	  33(11),	  3279-­‐3305.	  
	  
Pellegrini,	   S.,	   Cantarelli,	   E.,	   Sordi,	   V.,	   Nano,	   R.,	   &	   Piemonti,	   L.	   (2016).	   The	   state	   of	   the	   art	   of	   islet	  
transplantation	  and	  cell	  therapy	  in	  type	  1	  diabetes.	  Acta	  diabetologica,	  53(5),	  683-­‐691.	  
	  
Penko,	   D.,	   Rojas-­‐Canales,	   D.,	   Mohanasundaram,	   D.,	   Peiris,	   H.	   S.,	   Sun,	   W.	   Y.,	   Drogemuller,	   C.	   J.,	   ...	   &	  
Jessup,	  C.	  F.	  (2015).	  Endothelial	  progenitor	  cells	  enhance	  islet	  engraftment,	  influence	  β-­‐cell	  function,	  
and	  modulate	  islet	  connexin	  36	  expression.	  Cell	  transplantation,	  24(1),	  37-­‐48.	  
	  
Pepper,	   A.	   R.,	   Gala-­‐Lopez,	   B.,	   Ziff,	   O.,	   &	   Shapiro,	   A.	   M.	   (2013).	   Revascularization	   of	   transplanted	  







41	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
Perets,	   A.,	   Baruch,	   Y.,	   Weisbuch,	   F.,	   Shoshany,	   G.,	   Neufeld,	   G.,	   &	   Cohen,	   S.	   (2003).	   Enhancing	   the	  
vascularization	   of	   three-­‐dimensional	   porous	   alginate	   scaffolds	   by	   incorporating	   controlled	   release	  
basic	   fibroblast	   growth	   factor	  microspheres.	  Journal	   of	  Biomedical	  Materials	  Research	  Part	  A,	  65(4),	  
489-­‐497.	  
	  
Quan,	   H.,	   Tan,	   H.,	   Li,	   Q.,	   Li,	   J.,	   &	   Li,	   S.	   (2015).	   Immunological	   hypoglycemia	   associated	  with	   insulin	  
antibodies	   induced	   by	   exogenous	   insulin	   in	   11	   chinese	   patients	   with	   diabetes.	  Journal	   of	   diabetes	  
research,	  2015.	  
	  
Robertson,	  R.	  P.	  (2002).	  Intrahepatically	  transplanted	  islets—strangers	  in	  a	  strange	  land.	  The	  Journal	  
of	  Clinical	  Endocrinology	  &	  Metabolism,	  87(12),	  5416-­‐5417.	  
	  
Robertson,	  R.	   P.	   (2004).	   Islet	   transplantation	   as	   a	   treatment	   for	  diabetes—a	  work	   in	  progress.	  New	  
England	  Journal	  of	  Medicine,	  350(7),	  694-­‐705.	  
	  
Robertson,	  R.	  P.	   (2015).	   Islet	   transplantation	   for	   type	  1	  diabetes,	  2015:	  what	  have	  we	   learned	   from	  
alloislet	  and	  autoislet	  successes?.	  Diabetes	  care,	  38(6),	  1030-­‐1035.	  
	  
Roncalli,	   J.	   G.,	   Tongers,	   J.,	   Renault,	   M.	   A.,	   &	   Losordo,	   D.	   W.	   (2008).	   Endothelial	   progenitor	   cells	   in	  
regenerative	  medicine	  and	  cancer:	  a	  decade	  of	  research.	  Trends	  in	  biotechnology,	  26(5),	  276-­‐283.	  
	  
Rother,	  K.	  I.,	  &	  Harlan,	  D.	  M.	  (2004).	  Challenges	  facing	  islet	  transplantation	  for	  the	  treatment	  of	  type	  1	  
diabetes	  mellitus.	  The	  Journal	  of	  clinical	  investigation,	  114(7),	  877-­‐883.	  
	  
Rouwkema,	   J.,	   Rivron,	   N.	   C.,	   &	   van	   Blitterswijk,	   C.	   A.	   (2008).	   Vascularization	   in	   tissue	  
engineering.	  Trends	  in	  biotechnology,	  26(8),	  434-­‐441.	  
	  
Rouwkema,	  J.,	  &	  Khademhosseini,	  A.	  (2016).	  Vascularization	  and	  angiogenesis	   in	  tissue	  engineering:	  
beyond	  creating	  static	  networks.	  Trends	  in	  biotechnology.	  
	  
Ryan,	  E.	  A.,	  Paty,	  B.	  W.,	  Senior,	  P.	  A.,	  Bigam,	  D.,	  Alfadhli,	  E.,	  Kneteman,	  N.	  M.,	  ...	  &	  Shapiro,	  A.	  J.	  (2005).	  
Five-­‐year	  follow-­‐up	  after	  clinical	  islet	  transplantation.	  Diabetes,	  54(7),	  2060-­‐2069.	  
	  
Schweicher,	   J.,	   Nyitray,	   C.,	   &	   Desai,	   T.	   A.	   (2014).	   Membranes	   to	   achieve	   immunoprotection	   of	  
transplanted	  islets.	  Frontiers	  in	  bioscience	  (Landmark	  edition),	  19,	  49.	  
	  
Shafiee,	  A.,	  &	  Atala,	  A.	   (2016).	  Tissue	  Engineering:	  Toward	  a	  New	  Era	  of	  Medicine.	  Annual	  review	  of	  
medicine.	  
	  
Shah,	  V.	  N.,	  Moser,	  E.	  G.,	  Blau,	  A.,	  Dhingra,	  M.,	  &	  Garg,	  S.	  K.	  (2013).	  The	  future	  of	  basal	  insulin.	  Diabetes	  
technology	  &	  therapeutics,	  15(9),	  727-­‐732.	  
	  
Shah,	  R.	  B.,	  Patel,	  M.,	  Maahs,	  D.	  M.,	  &	  Shah,	  V.	  N.	  (2016).	   Insulin	  delivery	  methods:	  Past,	  present	  and	  
future.	  International	  journal	  of	  pharmaceutical	  investigation,	  6(1),	  1.	  
	  
Shapiro,	  A.	  J.,	  Lakey,	  J.	  R.,	  Ryan,	  E.	  A.,	  Korbutt,	  G.	  S.,	  Toth,	  E.,	  Warnock,	  G.	  L.,	   ...	  &	  Rajotte,	  R.	  V.	  (2000).	  
Islet	   transplantation	   in	   seven	   patients	   with	   type	   1	   diabetes	   mellitus	   using	   a	   glucocorticoid-­‐free	  
immunosuppressive	  regimen.	  New	  England	  Journal	  of	  Medicine,	  343(4),	  230-­‐238.	  
	  
Shapiro,	  A.	   J.,	  Ricordi,	  C.,	  Hering,	  B.	   J.,	  Auchincloss,	  H.,	  Lindblad,	  R.,	  Robertson,	  R.	  P.,	   ...	  &	  Cagliero,	  E.	  
(2006).	  International	  trial	  of	  the	  Edmonton	  protocol	  for	  islet	  transplantation.	  New	  England	  Journal	  of	  
Medicine,	  355(13),	  1318-­‐1330.	  
	  
Shoichet,	   M.	   S.,	   Li,	   R.	   H.,	   White,	   M.	   L.,	   &	   Winn,	   S.	   R.	   (1996).	   Stability	   of	   hydrogels	   used	   in	   cell	  
encapsulation:	   An	   in	   vitro	   comparison	   of	   alginate	   and	   agarose.	  Biotechnology	   and	  
bioengineering,	  50(4),	  374-­‐381.	  
	  
Skelin,	  M.,	  Rupnik,	  M.,	  &	  Cencic,	  A.	  (2010).	  Pancreatic	  beta	  cell	  lines	  and	  their	  applications	  in	  diabetes	  






42	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
	  
Slaughter,	  B.	  V.,	  Khurshid,	  S.	  S.,	  Fisher,	  O.	  Z.,	  Khademhosseini,	  A.,	  &	  Peppas,	  N.	  A.	  (2009).	  Hydrogels	  in	  
regenerative	  medicine.	  Advanced	  materials,	  21(32-­‐33),	  3307-­‐3329.	  
	  
Steiner,	  D.	  J.,	  Kim,	  A.,	  Miller,	  K.,	  &	  Hara,	  M.	  (2010).	  Pancreatic	  islet	  plasticity:	  interspecies	  comparison	  
of	  islet	  architecture	  and	  composition.	  Islets,	  2(3),	  135-­‐145.	  
	  
Stendahl,	  J.	  C.,	  Kaufman,	  D.	  B.,	  &	  Stupp,	  S.	  I.	  (2009).	  Extracellular	  matrix	  in	  pancreatic	  islets:	  relevance	  
to	  scaffold	  design	  and	  transplantation.	  Cell	  transplantation,	  18(1),	  1-­‐12.	  
	  
Stull,	  N.	  D.,	  Breite,	  A.,	  McCarthy,	  R.,	  Tersey,	  S.	  A.,	  &	  Mirmira,	  R.	  G.	   (2012).	  Mouse	   islet	  of	  Langerhans	  
isolation	  using	  a	  combination	  of	  purified	  collagenase	  and	  neutral	  protease.	  JoVE	  (Journal	  of	  Visualized	  
Experiments),	  (67),	  e4137-­‐e4137.	  
	  
Takahashi,	   Y.,	   Takebe,	   T.,	   &	   Taniguchi,	   H.	   (2016).	   Engineering	   pancreatic	   tissues	   from	   stem	   cells	  
towards	  therapy.	  Regenerative	  Therapy,	  3,	  15-­‐23.	  
	  
Tomky,	   D.	   (2005).	   Detection,	   prevention,	   and	   treatment	   of	   hypoglycemia	   in	   the	   hospital.	  Diabetes	  
Spectrum,	  18(1),	  39-­‐44.	  
	  
Tuomi,	  T.	  (2005).	  Type	  1	  and	  type	  2	  diabetes.	  Diabetes,	  54(suppl	  2),	  S40-­‐S45.	  
	  
Ulrich,	  A.	  B.,	  Schmied,	  B.	  M.,	  Standop,	  J.,	  Schneider,	  M.	  B.,	  &	  Pour,	  P.	  M.	  (2002).	  Pancreatic	  cell	  lines:	  a	  
review.	  Pancreas,	  24(2),	  111-­‐120.	  
	  
Vaithilingam,	  V.,	  &	  Tuch,	  B.	   E.	   (2011).	   Islet	   transplantation	   and	   encapsulation:	   an	  update	   on	   recent	  
developments.	  The	  review	  of	  diabetic	  studies:	  RDS,	  8(1),	  51.	  
	  
Van	   den	   Steen,	   P.	   E.,	   Dubois,	   B.,	   Nelissen,	   I.,	   Rudd,	   P.	   M.,	   Dwek,	   R.	   A.,	   &	   Opdenakker,	   G.	   (2002).	  
Biochemistry	  and	  molecular	  biology	  of	  gelatinase	  B	  or	  matrix	  metalloproteinase-­‐9	  (MMP-­‐9).	  Critical	  
reviews	  in	  biochemistry	  and	  molecular	  biology,	  37(6),	  375-­‐536.	  
	  
Vendamme,	  R.,	  Onoue,	  S.	  Y.,	  Nakao,	  A.,	  &	  Kunitake,	  T.	  (2006).	  Robust	  free-­‐standing	  nanomembranes	  of	  
organic/inorganic	  interpenetrating	  networks.	  Nature	  materials,	  5(6),	  494-­‐501.	  
	  
Yao,	   R.,	   Zhang,	   R.,	   Luan,	   J.,	   &	   Lin,	   F.	   (2012).	   Alginate	   and	   alginate/gelatin	  microspheres	   for	   human	  
adipose-­‐derived	  stem	  cell	  encapsulation	  and	  differentiation.	  Biofabrication,	  4(2),	  025007.	  
	  
Yue,	  Z.,	  Liu,	  X.,	  Coates,	  P.	  T.,	  &	  Wallace,	  G.	  G.	  (2016).	  Advances	  in	  printing	  biomaterials	  and	  living	  cells:	  
implications	  for	  islet	  cell	  transplantation.	  Current	  opinion	  in	  organ	  transplantation,	  21(5),	  467-­‐475.	  
	  
Yue,	  K.,	  Trujillo-­‐de	  Santiago,	  G.,	  Alvarez,	  M.	  M.,	  Tamayol,	  A.,	  Annabi,	  N.,	  &	  Khademhosseini,	  A.	  (2015).	  
Synthesis,	   properties,	   and	   biomedical	   applications	   of	   gelatin	   methacryloyl	   (GelMA)	  
hydrogels.	  Biomaterials,	  73,	  254-­‐271.	  
	  
Zimmermann,	  H.,	  Shirley,	  S.	  G.,	  &	  Zimmermann,	  U.	  (2007).	  Alginate-­‐based	  encapsulation	  of	  cells:	  past,	  
present,	  and	  future.	  Current	  diabetes	  reports,	  7(4),	  314-­‐320.	  
	  
Zhao,	  Y.,	  Li,	  Y.,	  Mao,	  S.,	  Sun,	  W.,	  &	  Yao,	  R.	  (2015).	  The	  influence	  of	  printing	  parameters	  on	  cell	  survival	  
rate	   and	   printability	   in	   microextrusion-­‐based	   3D	   cell	   printing	   technology.	  Biofabrication,	  7(4),	  
045002.	  
	  
Zuidema,	   J.	   M.,	   Rivet,	   C.	   J.,	   Gilbert,	   R.	   J.,	   &	   Morrison,	   F.	   A.	   (2014).	   A	   protocol	   for	   rheological	  
characterization	   of	   hydrogels	   for	   tissue	   engineering	   strategies.	  Journal	   of	   Biomedical	   Materials	  










43	  	   Student:	  Sarah-­‐Sophia	  D.	  Carter	  
Co-­‐supervisors:	  Dr.	  Zhilian	  Yue,	  Dr.	  Xiao	  Liu	  
	  
	  
	   	  
15.	  Supplementary	  information	  
	  
	  
Figure	   S1.	  Schematic	  representation	  of	   the	  degradation	  assessment.	  Whereas	  most	  discs	  obtained	   from	  
2|5%	   w/v	   alginate|GelMA	   (output	   lightsource:	   15%,	   30%)	   lost	   stability	   after	   9	   days	   of	   culture,	   discs	  
obtained	   from	  2|7.5%	  w/v	   alginate|GelMA	   (output	   lightsource:	   15%)	  were,	  with	   a	   stability	   of	   21	   days,	  
more	   durable.	   Discs	   obtained	   from	   more	   strongly	   crosslinked	   2|7.5%	   w/v	   alginate|GelMA	   (output	  
lightsource:	   30%)	   and	   weakly	   crosslinking	   2|10	   w/v	   alginate|GelMA	   (output	   lightsource:	   15%)	  
demonstrated	  stability	  for	  28	  days.	  	  
	  	  	  
	  
	  
Figure	  S2.	   	  Strain	  sweeps	  of	  2|7.5%	  w/v,	  and	  2|10%	  w/v	  alginate|GelMA	  samples	  at	  15°C	  and	  23°C.	  Data	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Figure	  S3.	  Frequency	  sweeps	  of	  2|7.5%	  w/v,	  and	  2|10%	  w/v	  alginate|GelMA	  samples	  at	  15°C	  and	  23°C.	  
Data	  is	  presented	  in	  mean±sd	  (n=3).	  
	  
	  
Figure	  S4.	  Time	  sweeps	  of	  2|7.5%	  w/v,	  and	  2|10%	  w/v	  alginate|GelMA	  samples	  at	  15°C	  and	  23°C.	  Data	  is	  
presented	  in	  mean±sd	  (n=3).	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Figure	   S5.	   Beta-­‐TC-­‐6	   and	  MS1	   cells	   encapsulated	   in	   2|7.5%	   and	   2|10%	  w/v	   alginate|GelMA	   over	   a	  





	   	  
	  
Figure	   S6.	   Left:	  plain	  2|7.5%	  w/v	  alginate|GelMA	  bulk	   constructs	  after	  4	  days	   in	   culture,	   exposed	   to	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Abstract	  
To	  gain	  a	  better	  understanding	  of	  the	  underlying	  mechanisms	  of	  disease,	  relevant	  tissue	  
models	  are	   imperative.	  Over	   the	  years,	   this	   realization	  has	   fuelled	   the	  development	  of	  
novel	  tools	  and	  platforms,	  which	  aim	  at	  capturing	  in	  vivo	  complexity.	  One	  example	  is	  the	  
field	   of	   biofabrication,	   which	   focusses	   on	   fabrication	   of	   three-­‐dimensional	   (3D)	  
biologically	   functional	   products	   in	   a	   controlled	   and	   automated	   manner.	   Herein,	   we	  
provide	   an	   overview	   of	   biofabrication	   technology	   and	   its	   potential	   to	   advance	   3D	  
neuronal	  cell	  culture,	  with	  special	  emphasis	  on	  neurodegenerative	  disease.	  In	  addition,	  
we	  highlight	  relevant	  translational	  bottlenecks,	  which	  will	  need	  to	  be	  considered	  as	  the	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